These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
Filed on Feb. 28, 2025 |
|
Filed on March 1, 2024 |
|
Filed on March 3, 2023 |
|
Filed on March 4, 2022 |
|
Filed on March 5, 2021 |
|
Filed on Feb. 28, 2020 |
Commission
File Number
|
Exact Name of Registrant as Specified in its Charter,
Principal Office Address and Telephone Number
|
State of Incorporation or
Organization
|
I.R.S. Employer
Identification No.
|
001-38646
|
Dow Inc.
|
Delaware
|
30-1128146
|
|
2211 H.H. Dow Way, Midland, MI 48674
|
|
|
|
(989) 636-1000
|
|
|
001-03433
|
The Dow Chemical Company
|
Delaware
|
38-1285128
|
|
2211 H.H. Dow Way, Midland, MI 48674
|
|
|
|
(989) 636-1000
|
|
|
Dow Inc.
|
Large accelerated filer
¨
|
Accelerated
filer
¨
|
Non-accelerated filer
þ
|
Smaller reporting company
¨
|
Emerging growth company
¨
|
The Dow Chemical Company
|
Large accelerated filer
¨
|
Accelerated
filer
¨
|
Non-accelerated filer
þ
|
Smaller reporting company
¨
|
Emerging growth company
¨
|
Registrant
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Dow Inc.
|
Common Stock, par value $0.01 per share
|
DOW
|
New York Stock Exchange
|
The Dow Chemical Company
|
4.625% Notes due October 1, 2044
|
DOW/44
|
New York Stock Exchange
|
|
|
PAGE
|
|
|
|
|
||
|
|
|
Item 1.
|
||
|
Dow Inc. and Subsidiaries:
|
|
|
||
|
||
|
||
|
||
|
||
|
|
|
|
The Dow Chemical Company and Subsidiaries:
|
|
|
||
|
||
|
||
|
||
|
||
|
|
|
|
Dow Inc. and Subsidiaries and The Dow Chemical Company and Subsidiaries:
|
|
|
|
|
|
||
|
|
|
Item 2.
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
Item 3.
|
||
|
|
|
Item 4.
|
||
|
|
|
|
||
|
|
|
Item 1.
|
||
|
|
|
Item 1A.
|
||
|
|
|
Item 2.
|
||
|
|
|
Item 4.
|
||
|
|
|
Item 5.
|
||
|
|
|
Item 6.
|
Exhibits
.
|
|
|
|
|
Dow Inc. and Subsidiaries
The Dow Chemical Company and Subsidiaries
|
PART I – FINANCIAL INFORMATION
|
|
Three Months Ended
|
Six Months Ended
|
||||||||||
In millions, except per share amounts (Unaudited)
|
Jun 30,
2019 |
Jun 30,
2018 |
Jun 30,
2019 |
Jun 30,
2018 |
||||||||
Net sales
|
$
|
11,014
|
|
$
|
12,789
|
|
$
|
21,983
|
|
$
|
25,026
|
|
Cost of sales
|
9,420
|
|
10,540
|
|
18,562
|
|
20,520
|
|
||||
Research and development expenses
|
208
|
|
221
|
|
398
|
|
429
|
|
||||
Selling, general and administrative expenses
|
422
|
|
485
|
|
870
|
|
967
|
|
||||
Amortization of intangibles
|
104
|
|
118
|
|
220
|
|
236
|
|
||||
Restructuring and asset related charges - net
|
65
|
|
40
|
|
221
|
|
127
|
|
||||
Integration and separation costs
|
348
|
|
262
|
|
800
|
|
486
|
|
||||
Equity in earnings (losses) of nonconsolidated affiliates
|
(15
|
)
|
193
|
|
(29
|
)
|
394
|
|
||||
Sundry income (expense) - net
|
(1
|
)
|
(14
|
)
|
68
|
|
40
|
|
||||
Interest income
|
21
|
|
18
|
|
39
|
|
38
|
|
||||
Interest expense and amortization of debt discount
|
237
|
|
261
|
|
478
|
|
523
|
|
||||
Income from continuing operations before income taxes
|
215
|
|
1,059
|
|
512
|
|
2,210
|
|
||||
Provision for income taxes on continuing operations
|
125
|
|
249
|
|
266
|
|
475
|
|
||||
Income from continuing operations, net of tax
|
90
|
|
810
|
|
246
|
|
1,735
|
|
||||
Income from discontinued operations, net of tax
|
—
|
|
554
|
|
445
|
|
1,068
|
|
||||
Net income
|
90
|
|
1,364
|
|
691
|
|
2,803
|
|
||||
Net income attributable to noncontrolling interests
|
15
|
|
31
|
|
60
|
|
66
|
|
||||
Net income available for Dow Inc. common stockholders
|
$
|
75
|
|
$
|
1,333
|
|
$
|
631
|
|
$
|
2,737
|
|
|
|
|
|
|
|
|
|
|
||||
Per common share data:
|
|
|
|
|
|
|
|
|
||||
Earnings per common share from continuing operations - basic
|
$
|
0.10
|
|
$
|
1.05
|
|
$
|
0.26
|
|
$
|
2.26
|
|
Earnings per common share from discontinued operations - basic
|
—
|
|
0.73
|
|
0.58
|
|
1.40
|
|
||||
Earnings per common share - basic
|
$
|
0.10
|
|
$
|
1.78
|
|
$
|
0.84
|
|
$
|
3.66
|
|
Earnings per common share from continuing operations - diluted
|
$
|
0.10
|
|
$
|
1.05
|
|
$
|
0.26
|
|
$
|
2.26
|
|
Earnings per common share from discontinued operations - diluted
|
—
|
|
0.73
|
|
0.58
|
|
1.40
|
|
||||
Earnings per common share - diluted
|
$
|
0.10
|
|
$
|
1.78
|
|
$
|
0.84
|
|
$
|
3.66
|
|
|
|
|
|
|
|
|
|
|
||||
Weighted-average common shares outstanding - basic
|
742.8
|
|
747.2
|
|
745.0
|
|
747.2
|
|
||||
Weighted-average common shares outstanding - diluted
|
747.9
|
|
747.2
|
|
747.6
|
|
747.2
|
|
||||
|
|
|
|
|
||||||||
Depreciation
|
$
|
538
|
|
$
|
540
|
|
$
|
1,081
|
|
$
|
1,094
|
|
Capital expenditures
|
$
|
470
|
|
$
|
489
|
|
$
|
912
|
|
$
|
868
|
|
|
Three Months Ended
|
Six Months Ended
|
||||||||||
In millions (Unaudited)
|
Jun 30,
2019 |
Jun 30,
2018 |
Jun 30,
2019 |
Jun 30,
2018 |
||||||||
Net income
|
$
|
90
|
|
$
|
1,364
|
|
$
|
691
|
|
$
|
2,803
|
|
Other comprehensive income (loss), net of tax
|
|
|
|
|
||||||||
Unrealized gains (losses) on investments
|
33
|
|
(14
|
)
|
100
|
|
(39
|
)
|
||||
Cumulative translation adjustments
|
67
|
|
(470
|
)
|
36
|
|
(94
|
)
|
||||
Pension and other postretirement benefit plans
|
106
|
|
124
|
|
247
|
|
250
|
|
||||
Derivative instruments
|
(204
|
)
|
118
|
|
(279
|
)
|
124
|
|
||||
Total other comprehensive income (loss)
|
2
|
|
(242
|
)
|
104
|
|
241
|
|
||||
Comprehensive income
|
92
|
|
1,122
|
|
795
|
|
3,044
|
|
||||
Comprehensive income (loss) attributable to noncontrolling interests, net of tax
|
21
|
|
(1
|
)
|
72
|
|
27
|
|
||||
Comprehensive income attributable to Dow Inc.
|
$
|
71
|
|
$
|
1,123
|
|
$
|
723
|
|
$
|
3,017
|
|
In millions, except share amounts (Unaudited)
|
Jun 30,
2019 |
Dec 31,
2018 |
||||
Assets
|
|
|
||||
Current Assets
|
|
|
||||
Cash and cash equivalents (variable interest entities restricted - 2019: $26; 2018: $71)
|
$
|
2,446
|
|
$
|
2,724
|
|
Marketable securities
|
20
|
|
100
|
|
||
Accounts and notes receivable:
|
|
|
||||
Trade (net of allowance for doubtful receivables - 2019: $40; 2018: $42)
|
5,661
|
|
5,646
|
|
||
Other
|
2,908
|
|
3,389
|
|
||
Inventories
|
6,841
|
|
6,899
|
|
||
Other current assets
|
761
|
|
712
|
|
||
Assets of discontinued operations - current
|
—
|
|
19,900
|
|
||
Total current assets
|
18,637
|
|
39,370
|
|
||
Investments
|
|
|
||||
Investment in nonconsolidated affiliates
|
2,968
|
|
3,320
|
|
||
Other investments (investments carried at fair value - 2019: $1,688; 2018: $1,699)
|
2,558
|
|
2,646
|
|
||
Noncurrent receivables
|
785
|
|
360
|
|
||
Total investments
|
6,311
|
|
6,326
|
|
||
Property
|
|
|
||||
Property
|
54,937
|
|
53,984
|
|
||
Less accumulated depreciation
|
33,687
|
|
32,566
|
|
||
Net property (variable interest entities restricted - 2019: $657; 2018: $683)
|
21,250
|
|
21,418
|
|
||
Other Assets
|
|
|
||||
Goodwill
|
9,848
|
|
9,846
|
|
||
Other intangible assets (net of accumulated amortization - 2019: $3,657; 2018: $3,379)
|
4,000
|
|
4,225
|
|
||
Operating lease right-of-use assets
|
2,183
|
|
—
|
|
||
Deferred income tax assets
|
1,857
|
|
1,779
|
|
||
Deferred charges and other assets
|
803
|
|
735
|
|
||
Total other assets
|
18,691
|
|
16,585
|
|
||
Total Assets
|
$
|
64,889
|
|
$
|
83,699
|
|
Liabilities and Equity
|
|
|
||||
Current Liabilities
|
|
|
||||
Notes payable
|
$
|
544
|
|
$
|
298
|
|
Long-term debt due within one year
|
297
|
|
338
|
|
||
Accounts payable:
|
|
|
||||
Trade
|
4,188
|
|
4,456
|
|
||
Other
|
2,179
|
|
2,479
|
|
||
Operating lease liabilities - current
|
421
|
|
—
|
|
||
Income taxes payable
|
370
|
|
557
|
|
||
Accrued and other current liabilities
|
3,606
|
|
2,931
|
|
||
Liabilities of discontinued operations - current
|
—
|
|
4,488
|
|
||
Total current liabilities
|
11,605
|
|
15,547
|
|
||
Long-Term Debt (variable interest entities nonrecourse - 2019: $45; 2018: $75)
|
17,155
|
|
19,253
|
|
||
Other Noncurrent Liabilities
|
|
|
||||
Deferred income tax liabilities
|
500
|
|
501
|
|
||
Pension and other postretirement benefits - noncurrent
|
8,674
|
|
8,926
|
|
||
Asbestos-related liabilities - noncurrent
|
1,113
|
|
1,142
|
|
||
Operating lease liabilities - noncurrent
|
1,779
|
|
—
|
|
||
Other noncurrent obligations
|
5,563
|
|
4,709
|
|
||
Total other noncurrent liabilities
|
17,629
|
|
15,278
|
|
||
Stockholders’ Equity
|
|
|
||||
Common stock (authorized 5,000,000,000 shares of $0.01 par value each;
issued 2019: 749,025,762 shares; 2018: 100 shares)
|
7
|
|
—
|
|
||
Additional paid-in capital
|
7,186
|
|
7,042
|
|
||
Retained earnings
|
20,110
|
|
35,460
|
|
||
Accumulated other comprehensive loss
|
(8,988
|
)
|
(9,885
|
)
|
||
Unearned ESOP shares
|
(99
|
)
|
(134
|
)
|
||
Treasury stock at cost (2019: 5,813,756 shares; 2018: zero shares)
|
(305
|
)
|
—
|
|
||
Dow Inc.’s stockholders’ equity
|
17,911
|
|
32,483
|
|
||
Noncontrolling interests
|
589
|
|
1,138
|
|
||
Total equity
|
18,500
|
|
33,621
|
|
||
Total Liabilities and Equity
|
$
|
64,889
|
|
$
|
83,699
|
|
In millions (Unaudited)
|
Six Months Ended
|
|||||
Jun 30,
2019 |
Jun 30,
2018 |
|||||
Operating Activities
|
|
|
||||
Net income
|
$
|
691
|
|
$
|
2,803
|
|
Less: Income from discontinued operations, net of tax
|
445
|
|
1,068
|
|
||
Income from continuing operations, net of tax
|
246
|
|
1,735
|
|
||
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
||||
Depreciation and amortization
|
1,486
|
|
1,451
|
|
||
Provision (credit) for deferred income tax
|
(63
|
)
|
7
|
|
||
Earnings of nonconsolidated affiliates less than dividends received
|
880
|
|
196
|
|
||
Net periodic pension benefit cost
|
57
|
|
169
|
|
||
Pension contributions
|
(152
|
)
|
(373
|
)
|
||
Net gain on sales of assets, businesses and investments
|
(27
|
)
|
(26
|
)
|
||
Adjustment to gain on step acquisition of nonconsolidated affiliate
|
—
|
|
20
|
|
||
Restructuring and asset related charges - net
|
221
|
|
127
|
|
||
Other net loss
|
115
|
|
241
|
|
||
Changes in assets and liabilities, net of effects of acquired and divested companies:
|
|
|
||||
Accounts and notes receivable
|
239
|
|
(1,115
|
)
|
||
Inventories
|
58
|
|
(912
|
)
|
||
Accounts payable
|
(450
|
)
|
1,299
|
|
||
Other assets and liabilities, net
|
(607
|
)
|
(1,315
|
)
|
||
Cash provided by operating activities - continuing operations
|
2,003
|
|
1,504
|
|
||
Cash provided by operating activities - discontinued operations
|
253
|
|
289
|
|
||
Cash provided by operating activities
|
2,256
|
|
1,793
|
|
||
Investing Activities
|
|
|
||||
Capital expenditures
|
(912
|
)
|
(868
|
)
|
||
Investment in gas field developments
|
(48
|
)
|
(46
|
)
|
||
Purchases of previously leased assets
|
(9
|
)
|
—
|
|
||
Proceeds from sales of property and businesses, net of cash divested
|
9
|
|
14
|
|
||
Investments in and loans to nonconsolidated affiliates
|
(228
|
)
|
(2
|
)
|
||
Distributions and loan repayments from nonconsolidated affiliates
|
—
|
|
55
|
|
||
Purchases of investments
|
(393
|
)
|
(900
|
)
|
||
Proceeds from sales and maturities of investments
|
735
|
|
751
|
|
||
Proceeds from interests in trade accounts receivable conduits
|
—
|
|
656
|
|
||
Cash used for investing activities - continuing operations
|
(846
|
)
|
(340
|
)
|
||
Cash used for investing activities - discontinued operations
|
(34
|
)
|
(112
|
)
|
||
Cash used for investing activities
|
(880
|
)
|
(452
|
)
|
||
Financing Activities
|
|
|
||||
Changes in short-term notes payable
|
162
|
|
345
|
|
||
Proceeds from issuance of long-term debt
|
2,010
|
|
—
|
|
||
Payments on long-term debt
|
(4,221
|
)
|
(568
|
)
|
||
Purchases of treasury stock
|
(305
|
)
|
—
|
|
||
Proceeds from issuance of parent company stock
|
34
|
|
85
|
|
||
Transaction financing, debt issuance and other costs
|
(56
|
)
|
—
|
|
||
Employee taxes paid for share-based payment arrangements
|
(50
|
)
|
(70
|
)
|
||
Distributions to noncontrolling interests
|
(7
|
)
|
(39
|
)
|
||
Purchases of noncontrolling interests
|
(127
|
)
|
—
|
|
||
Dividends paid to stockholders
|
(517
|
)
|
—
|
|
||
Dividends paid to DowDuPont Inc.
|
(535
|
)
|
(2,110
|
)
|
||
Settlements and transfers related to separation from DowDuPont Inc.
|
1,963
|
|
(215
|
)
|
||
Other financing activities, net
|
—
|
|
3
|
|
||
Cash used for financing activities - continuing operations
|
(1,649
|
)
|
(2,569
|
)
|
||
Cash used for financing activities - discontinued operations
|
(18
|
)
|
(43
|
)
|
||
Cash used for financing activities
|
(1,667
|
)
|
(2,612
|
)
|
||
Effect of exchange rate changes on cash, cash equivalents and restricted cash
|
10
|
|
(69
|
)
|
||
Summary
|
|
|
||||
Decrease in cash, cash equivalents and restricted cash
|
(281
|
)
|
(1,340
|
)
|
||
Cash, cash equivalents and restricted cash at beginning of period
|
2,764
|
|
6,208
|
|
||
Cash, cash equivalents and restricted cash at end of period
|
$
|
2,483
|
|
$
|
4,868
|
|
Less: Restricted cash and cash equivalents, included in "Other current assets"
|
37
|
|
45
|
|
||
Cash and cash equivalents at end of period
|
$
|
2,446
|
|
$
|
4,823
|
|
|
Three Months Ended
|
Six Months Ended
|
||||||||||
In millions (Unaudited)
|
Jun 30,
2019 |
Jun 30,
2018 |
Jun 30,
2019 |
Jun 30,
2018 |
||||||||
Common Stock
|
|
|
|
|
||||||||
Balance at beginning of period
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
Common stock issued
|
7
|
|
—
|
|
7
|
|
—
|
|
||||
Balance at end of period
|
7
|
|
—
|
|
7
|
|
—
|
|
||||
Additional Paid-in Capital
|
|
|
|
|
||||||||
Balance at beginning of period
|
7,153
|
|
6,758
|
|
7,042
|
|
6,553
|
|
||||
Common stock issued/sold
|
(1
|
)
|
—
|
|
(1
|
)
|
—
|
|
||||
Issuance of parent company stock - DowDuPont Inc.
|
—
|
|
22
|
|
28
|
|
85
|
|
||||
Stock-based compensation and allocation of ESOP shares
|
64
|
|
81
|
|
147
|
|
223
|
|
||||
Other
|
(30
|
)
|
—
|
|
(30
|
)
|
—
|
|
||||
Balance at end of period
|
7,186
|
|
6,861
|
|
7,186
|
|
6,861
|
|
||||
Retained Earnings
|
|
|
|
|
||||||||
Balance at beginning of period
|
35,403
|
|
33,899
|
|
35,460
|
|
33,742
|
|
||||
Net income available for Dow Inc. common stockholders
|
75
|
|
1,333
|
|
631
|
|
2,737
|
|
||||
Dividends to stockholders
|
(517
|
)
|
—
|
|
(517
|
)
|
—
|
|
||||
Dividends to parent - DowDuPont Inc.
|
—
|
|
(1,053
|
)
|
(535
|
)
|
(2,110
|
)
|
||||
Common control transaction
|
(14,846
|
)
|
(37
|
)
|
(14,811
|
)
|
(152
|
)
|
||||
Adoption of accounting standards
|
—
|
|
1,057
|
|
(111
|
)
|
989
|
|
||||
Other
|
(5
|
)
|
(7
|
)
|
(7
|
)
|
(14
|
)
|
||||
Balance at end of period
|
20,110
|
|
35,192
|
|
20,110
|
|
35,192
|
|
||||
Accumulated Other Comprehensive Loss
|
|
|
|
|
||||||||
Balance at beginning of period
|
(9,783
|
)
|
(8,088
|
)
|
(9,885
|
)
|
(8,591
|
)
|
||||
Other comprehensive income (loss)
|
2
|
|
(242
|
)
|
104
|
|
241
|
|
||||
Common control transaction
|
793
|
|
—
|
|
793
|
|
—
|
|
||||
Adoption of accounting standards
|
—
|
|
(1,057
|
)
|
—
|
|
(1,037
|
)
|
||||
Balance at end of period
|
(8,988
|
)
|
(9,387
|
)
|
(8,988
|
)
|
(9,387
|
)
|
||||
Unearned ESOP Shares
|
|
|
|
|
||||||||
Balance at beginning of period
|
(105
|
)
|
(150
|
)
|
(134
|
)
|
(189
|
)
|
||||
Allocation of ESOP shares
|
6
|
|
5
|
|
35
|
|
44
|
|
||||
Balance at end of period
|
(99
|
)
|
(145
|
)
|
(99
|
)
|
(145
|
)
|
||||
Treasury Stock
|
|
|
|
|
||||||||
Balance at beginning of period
|
—
|
|
—
|
|
—
|
|
—
|
|
||||
Treasury stock purchases
|
(305
|
)
|
—
|
|
(305
|
)
|
—
|
|
||||
Balance at end of period
|
(305
|
)
|
—
|
|
(305
|
)
|
—
|
|
||||
Dow Inc.'s stockholders' equity
|
17,911
|
|
32,521
|
|
17,911
|
|
32,521
|
|
||||
Noncontrolling Interests
|
589
|
|
1,152
|
|
589
|
|
1,152
|
|
||||
Total Equity
|
$
|
18,500
|
|
$
|
33,673
|
|
$
|
18,500
|
|
$
|
33,673
|
|
|
|
|
|
|
||||||||
Dividends declared per share of common stock
|
$
|
0.70
|
|
$
|
—
|
|
$
|
0.70
|
|
$
|
—
|
|
|
Three Months Ended
|
Six Months Ended
|
||||||||||
In millions (Unaudited)
|
Jun 30,
2019 |
Jun 30,
2018 |
Jun 30,
2019 |
Jun 30,
2018 |
||||||||
Net sales
|
$
|
11,014
|
|
$
|
12,789
|
|
$
|
21,983
|
|
$
|
25,026
|
|
Cost of sales
|
9,419
|
|
10,540
|
|
18,561
|
|
20,520
|
|
||||
Research and development expenses
|
208
|
|
221
|
|
398
|
|
429
|
|
||||
Selling, general and administrative expenses
|
418
|
|
485
|
|
866
|
|
967
|
|
||||
Amortization of intangibles
|
104
|
|
118
|
|
220
|
|
236
|
|
||||
Restructuring and asset related charges - net
|
65
|
|
40
|
|
221
|
|
127
|
|
||||
Integration and separation costs
|
324
|
|
262
|
|
776
|
|
486
|
|
||||
Equity in earnings (losses) of nonconsolidated affiliates
|
(15
|
)
|
193
|
|
(29
|
)
|
394
|
|
||||
Sundry income (expense) - net
|
109
|
|
(14
|
)
|
178
|
|
40
|
|
||||
Interest income
|
21
|
|
18
|
|
39
|
|
38
|
|
||||
Interest expense and amortization of debt discount
|
249
|
|
261
|
|
490
|
|
523
|
|
||||
Income from continuing operations before income taxes
|
342
|
|
1,059
|
|
639
|
|
2,210
|
|
||||
Provision for income taxes on continuing operations
|
125
|
|
249
|
|
266
|
|
475
|
|
||||
Income from continuing operations, net of tax
|
217
|
|
810
|
|
373
|
|
1,735
|
|
||||
Income from discontinued operations, net of tax
|
—
|
|
554
|
|
445
|
|
1,068
|
|
||||
Net income
|
217
|
|
1,364
|
|
818
|
|
2,803
|
|
||||
Net income attributable to noncontrolling interests
|
15
|
|
31
|
|
60
|
|
66
|
|
||||
Net income available for The Dow Chemical Company common stockholder
|
$
|
202
|
|
$
|
1,333
|
|
$
|
758
|
|
$
|
2,737
|
|
|
|
|
|
|
||||||||
Depreciation
|
$
|
538
|
|
$
|
540
|
|
$
|
1,081
|
|
$
|
1,094
|
|
Capital expenditures
|
$
|
470
|
|
$
|
489
|
|
$
|
912
|
|
$
|
868
|
|
|
Three Months Ended
|
Six Months Ended
|
||||||||||
In millions (Unaudited)
|
Jun 30,
2019 |
Jun 30,
2018 |
Jun 30,
2019 |
Jun 30,
2018 |
||||||||
Net income
|
$
|
217
|
|
$
|
1,364
|
|
$
|
818
|
|
$
|
2,803
|
|
Other comprehensive income (loss), net of tax
|
|
|
|
|
||||||||
Unrealized gains (losses) on investments
|
33
|
|
(14
|
)
|
100
|
|
(39
|
)
|
||||
Cumulative translation adjustments
|
67
|
|
(470
|
)
|
36
|
|
(94
|
)
|
||||
Pension and other postretirement benefit plans
|
106
|
|
124
|
|
247
|
|
250
|
|
||||
Derivative instruments
|
(204
|
)
|
118
|
|
(279
|
)
|
124
|
|
||||
Total other comprehensive income (loss)
|
2
|
|
(242
|
)
|
104
|
|
241
|
|
||||
Comprehensive income
|
219
|
|
1,122
|
|
922
|
|
3,044
|
|
||||
Comprehensive income (loss) attributable to noncontrolling interests, net of tax
|
21
|
|
(1
|
)
|
72
|
|
27
|
|
||||
Comprehensive income attributable to The Dow Chemical Company
|
$
|
198
|
|
$
|
1,123
|
|
$
|
850
|
|
$
|
3,017
|
|
In millions, except share amounts (Unaudited)
|
Jun 30,
2019 |
Dec 31,
2018 |
||||
Assets
|
|
|
||||
Current Assets
|
|
|
||||
Cash and cash equivalents (variable interest entities restricted - 2019: $26; 2018: $71)
|
$
|
2,446
|
|
$
|
2,724
|
|
Marketable securities
|
20
|
|
100
|
|
||
Accounts and notes receivable:
|
|
|
||||
Trade (net of allowance for doubtful receivables - 2019: $40; 2018: $42)
|
5,661
|
|
5,646
|
|
||
Other
|
2,912
|
|
3,389
|
|
||
Inventories
|
6,841
|
|
6,899
|
|
||
Other current assets
|
588
|
|
712
|
|
||
Assets of discontinued operations - current
|
—
|
|
19,900
|
|
||
Total current assets
|
18,468
|
|
39,370
|
|
||
Investments
|
|
|
||||
Investment in nonconsolidated affiliates
|
2,968
|
|
3,320
|
|
||
Other investments (investments carried at fair value - 2019: $1,688; 2018: $1,699)
|
2,558
|
|
2,646
|
|
||
Noncurrent receivables
|
771
|
|
360
|
|
||
Total investments
|
6,297
|
|
6,326
|
|
||
Property
|
|
|
||||
Property
|
54,937
|
|
53,984
|
|
||
Less accumulated depreciation
|
33,687
|
|
32,566
|
|
||
Net property (variable interest entities restricted - 2019: $657; 2018: $683)
|
21,250
|
|
21,418
|
|
||
Other Assets
|
|
|
||||
Goodwill
|
9,848
|
|
9,846
|
|
||
Other intangible assets (net of accumulated amortization - 2019: $3,657; 2018: $3,379)
|
4,000
|
|
4,225
|
|
||
Operating lease right-of-use assets
|
2,183
|
|
—
|
|
||
Deferred income tax assets
|
1,857
|
|
1,779
|
|
||
Deferred charges and other assets
|
801
|
|
735
|
|
||
Total other assets
|
18,689
|
|
16,585
|
|
||
Total Assets
|
$
|
64,704
|
|
$
|
83,699
|
|
Liabilities and Equity
|
|
|
||||
Current Liabilities
|
|
|
||||
Notes payable
|
$
|
1,691
|
|
$
|
298
|
|
Long-term debt due within one year
|
297
|
|
338
|
|
||
Accounts payable:
|
|
|
||||
Trade
|
4,187
|
|
4,456
|
|
||
Other
|
2,179
|
|
2,479
|
|
||
Operating lease liabilities - current
|
421
|
|
—
|
|
||
Income taxes payable
|
370
|
|
557
|
|
||
Accrued and other current liabilities
|
3,072
|
|
2,931
|
|
||
Liabilities of discontinued operations - current
|
—
|
|
4,488
|
|
||
Total current liabilities
|
12,217
|
|
15,547
|
|
||
Long-Term Debt (variable interest entities nonrecourse - 2019: $45; 2018: $75)
|
17,155
|
|
19,253
|
|
||
Other Noncurrent Liabilities
|
|
|
||||
Deferred income tax liabilities
|
500
|
|
501
|
|
||
Pension and other postretirement benefits - noncurrent
|
8,674
|
|
8,926
|
|
||
Asbestos-related liabilities - noncurrent
|
1,113
|
|
1,142
|
|
||
Operating lease liabilities - noncurrent
|
1,779
|
|
—
|
|
||
Other noncurrent obligations
|
4,997
|
|
4,709
|
|
||
Total other noncurrent liabilities
|
17,063
|
|
15,278
|
|
||
Stockholder's Equity
|
|
|
||||
Common stock (authorized and issued 100 shares of $0.01 par value each)
|
—
|
|
—
|
|
||
Additional paid-in capital
|
7,192
|
|
7,042
|
|
||
Retained earnings
|
19,575
|
|
35,460
|
|
||
Accumulated other comprehensive loss
|
(8,988
|
)
|
(9,885
|
)
|
||
Unearned ESOP shares
|
(99
|
)
|
(134
|
)
|
||
The Dow Chemical Company’s stockholder's equity
|
17,680
|
|
32,483
|
|
||
Noncontrolling interests
|
589
|
|
1,138
|
|
||
Total equity
|
18,269
|
|
33,621
|
|
||
Total Liabilities and Equity
|
$
|
64,704
|
|
$
|
83,699
|
|
In millions (Unaudited)
|
Six Months Ended
|
|||||
Jun 30,
2019 |
Jun 30,
2018 |
|||||
Operating Activities
|
|
|
||||
Net income
|
$
|
818
|
|
$
|
2,803
|
|
Less: Income from discontinued operations, net of tax
|
445
|
|
1,068
|
|
||
Income from continuing operations, net of tax
|
373
|
|
1,735
|
|
||
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
||||
Depreciation and amortization
|
1,486
|
|
1,451
|
|
||
Provision (credit) for deferred income tax
|
(63
|
)
|
7
|
|
||
Earnings of nonconsolidated affiliates less than dividends received
|
880
|
|
196
|
|
||
Net periodic pension benefit cost
|
57
|
|
169
|
|
||
Pension contributions
|
(152
|
)
|
(373
|
)
|
||
Net gain on sales of assets, businesses and investments
|
(27
|
)
|
(26
|
)
|
||
Adjustment to gain on step acquisition of nonconsolidated affiliate
|
—
|
|
20
|
|
||
Restructuring and asset related charges - net
|
221
|
|
127
|
|
||
Other net loss
|
115
|
|
241
|
|
||
Changes in assets and liabilities, net of effects of acquired and divested companies:
|
|
|
|
|
||
Accounts and notes receivable
|
240
|
|
(1,115
|
)
|
||
Inventories
|
58
|
|
(912
|
)
|
||
Accounts payable
|
(451
|
)
|
1,299
|
|
||
Other assets and liabilities, net
|
(760
|
)
|
(1,315
|
)
|
||
Cash provided by operating activities - continuing operations
|
1,977
|
|
1,504
|
|
||
Cash provided by operating activities - discontinued operations
|
346
|
|
289
|
|
||
Cash provided by operating activities
|
2,323
|
|
1,793
|
|
||
Investing Activities
|
|
|
||||
Capital expenditures
|
(912
|
)
|
(868
|
)
|
||
Investment in gas field developments
|
(48
|
)
|
(46
|
)
|
||
Purchases of previously leased assets
|
(9
|
)
|
—
|
|
||
Proceeds from sales of property and businesses, net of cash divested
|
9
|
|
14
|
|
||
Investments in and loans to nonconsolidated affiliates
|
(228
|
)
|
(2
|
)
|
||
Distributions and loan repayments from nonconsolidated affiliates
|
—
|
|
55
|
|
||
Purchases of investments
|
(393
|
)
|
(900
|
)
|
||
Proceeds from sales and maturities of investments
|
735
|
|
751
|
|
||
Proceeds from interests in trade accounts receivable conduits
|
—
|
|
656
|
|
||
Cash used for investing activities - continuing operations
|
(846
|
)
|
(340
|
)
|
||
Cash used for investing activities - discontinued operations
|
(34
|
)
|
(112
|
)
|
||
Cash used for investing activities
|
(880
|
)
|
(452
|
)
|
||
Financing Activities
|
|
|
||||
Changes in short-term notes payable
|
162
|
|
345
|
|
||
Changes in notes payable with Dow Inc.
|
1,135
|
|
—
|
|
||
Proceeds from issuance of long-term debt
|
2,010
|
|
—
|
|
||
Payments on long-term debt
|
(4,221
|
)
|
(568
|
)
|
||
Proceeds from issuance of parent company stock
|
34
|
|
85
|
|
||
Transaction financing, debt issuance and other costs
|
(56
|
)
|
—
|
|
||
Employee taxes paid for share-based payment arrangements
|
(50
|
)
|
(70
|
)
|
||
Distributions to noncontrolling interests
|
(7
|
)
|
(39
|
)
|
||
Purchases of noncontrolling interests
|
(127
|
)
|
—
|
|
||
Dividends paid to DowDuPont Inc.
|
(535
|
)
|
(2,110
|
)
|
||
Settlements and transfers related to separation from DowDuPont Inc.
|
(61
|
)
|
(215
|
)
|
||
Other financing activities, net
|
—
|
|
3
|
|
||
Cash used for financing activities - continuing operations
|
(1,716
|
)
|
(2,569
|
)
|
||
Cash used for financing activities - discontinued operations
|
(18
|
)
|
(43
|
)
|
||
Cash used for financing activities
|
(1,734
|
)
|
(2,612
|
)
|
||
Effect of exchange rate changes on cash, cash equivalents and restricted cash
|
10
|
|
(69
|
)
|
||
Summary
|
|
|
||||
Decrease in cash, cash equivalents and restricted cash
|
(281
|
)
|
(1,340
|
)
|
||
Cash, cash equivalents and restricted cash at beginning of period
|
2,764
|
|
6,208
|
|
||
Cash, cash equivalents and restricted cash at end of period
|
$
|
2,483
|
|
$
|
4,868
|
|
Less: Restricted cash and cash equivalents, included in "Other current assets"
|
37
|
|
45
|
|
||
Cash and cash equivalents at end of period
|
$
|
2,446
|
|
$
|
4,823
|
|
|
Three Months Ended
|
Six Months Ended
|
||||||||||
In millions (Unaudited)
|
Jun 30,
2019 |
Jun 30,
2018 |
Jun 30,
2019 |
Jun 30,
2018 |
||||||||
Common Stock
|
|
|
|
|
||||||||
Balance at beginning and end of period
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
Additional Paid-in Capital
|
|
|
|
|
||||||||
Balance at beginning of period
|
7,153
|
|
6,758
|
|
7,042
|
|
6,553
|
|
||||
Issuance of parent company stock - Dow Inc.
|
6
|
|
—
|
|
6
|
|
—
|
|
||||
Issuance of parent company stock - DowDuPont Inc.
|
—
|
|
22
|
|
28
|
|
85
|
|
||||
Stock-based compensation and allocation of ESOP shares
|
64
|
|
81
|
|
147
|
|
223
|
|
||||
Other
|
(31
|
)
|
—
|
|
(31
|
)
|
—
|
|
||||
Balance at end of period
|
7,192
|
|
6,861
|
|
7,192
|
|
6,861
|
|
||||
Retained Earnings
|
|
|
|
|
||||||||
Balance at beginning of period
|
35,403
|
|
33,899
|
|
35,460
|
|
33,742
|
|
||||
Net income available for The Dow Chemical Company common stockholder
|
202
|
|
1,333
|
|
758
|
|
2,737
|
|
||||
Dividends to parent - DowDuPont Inc.
|
—
|
|
(1,053
|
)
|
(535
|
)
|
(2,110
|
)
|
||||
Common control transaction
|
(16,025
|
)
|
(37
|
)
|
(15,990
|
)
|
(152
|
)
|
||||
Adoption of accounting standards
|
—
|
|
1,057
|
|
(111
|
)
|
989
|
|
||||
Other
|
(5
|
)
|
(7
|
)
|
(7
|
)
|
(14
|
)
|
||||
Balance at end of period
|
19,575
|
|
35,192
|
|
19,575
|
|
35,192
|
|
||||
Accumulated Other Comprehensive Loss
|
|
|
|
|
||||||||
Balance at beginning of period
|
(9,783
|
)
|
(8,088
|
)
|
(9,885
|
)
|
(8,591
|
)
|
||||
Other comprehensive income (loss)
|
2
|
|
(242
|
)
|
104
|
|
241
|
|
||||
Common control transaction
|
793
|
|
—
|
|
793
|
|
—
|
|
||||
Adoption of accounting standards
|
—
|
|
(1,057
|
)
|
—
|
|
(1,037
|
)
|
||||
Balance at end of period
|
(8,988
|
)
|
(9,387
|
)
|
(8,988
|
)
|
(9,387
|
)
|
||||
Unearned ESOP Shares
|
|
|
|
|
||||||||
Balance at beginning of period
|
(105
|
)
|
(150
|
)
|
(134
|
)
|
(189
|
)
|
||||
Allocation of ESOP shares
|
6
|
|
5
|
|
35
|
|
44
|
|
||||
Balance at end of period
|
(99
|
)
|
(145
|
)
|
(99
|
)
|
(145
|
)
|
||||
The Dow Chemical Company's stockholder's equity
|
17,680
|
|
32,521
|
|
17,680
|
|
32,521
|
|
||||
Noncontrolling Interests
|
589
|
|
1,152
|
|
589
|
|
1,152
|
|
||||
Total Equity
|
$
|
18,269
|
|
$
|
33,673
|
|
$
|
18,269
|
|
$
|
33,673
|
|
Dow Inc. and Subsidiaries
The Dow Chemical Company and Subsidiaries
|
Note
|
|
Page
|
1
|
||
2
|
||
3
|
||
4
|
||
5
|
||
6
|
||
7
|
||
8
|
||
9
|
||
10
|
||
11
|
||
12
|
||
13
|
||
14
|
||
15
|
||
16
|
||
17
|
||
18
|
||
19
|
||
20
|
||
21
|
||
22
|
||
23
|
ECP Assets Received and Liabilities Assumed on Aug 31, 2017
|
Carrying value
|
||
In millions
|
|||
Cash and cash equivalents
|
$
|
1
|
|
Accounts and notes receivable - Trade
|
169
|
|
|
Accounts and notes receivable - Other
|
32
|
|
|
Inventories
|
529
|
|
|
Other current assets
|
6
|
|
|
Investment in nonconsolidated affiliates
|
116
|
|
|
Net property
|
817
|
|
|
Goodwill
|
3,617
|
|
|
Other intangible assets
|
1,484
|
|
|
Deferred income tax assets
|
9
|
|
|
Total Assets
|
$
|
6,780
|
|
Accounts payable - Trade
|
102
|
|
|
Accounts payable - Other
|
29
|
|
|
Accrued and other current liabilities
|
31
|
|
|
Deferred income tax liabilities
|
683
|
|
|
Pension and other postretirement benefits - noncurrent
|
6
|
|
|
Other noncurrent obligations
|
3
|
|
|
Total Liabilities
|
$
|
854
|
|
Net Assets (impact to "Retained earnings")
|
$
|
5,926
|
|
Results of Operations of AgCo and SpecCo
|
Three Months Ended
|
Six Months Ended
|
|||||||
|
Jun 30, 2018
|
Jun 30, 2019
|
Jun 30, 2018
|
||||||
In millions
|
|||||||||
Net sales
|
$
|
3,397
|
|
$
|
2,953
|
|
$
|
6,456
|
|
Cost of sales
|
2,123
|
|
1,804
|
|
3,948
|
|
|||
Research and development expenses
|
193
|
|
175
|
|
376
|
|
|||
Selling, general and administrative expenses
|
272
|
|
262
|
|
555
|
|
|||
Amortization of intangibles
|
63
|
|
61
|
|
127
|
|
|||
Restructuring and asset related charges - net
|
56
|
|
78
|
|
138
|
|
|||
Equity in earnings of nonconsolidated affiliates
|
41
|
|
28
|
|
83
|
|
|||
Sundry income (expense) - net
|
1
|
|
(18
|
)
|
5
|
|
|||
Interest income
|
3
|
|
3
|
|
11
|
|
|||
Interest expense and amortization of debt discount
|
12
|
|
7
|
|
21
|
|
|||
Income from discontinued operations before income taxes
|
$
|
723
|
|
$
|
579
|
|
$
|
1,390
|
|
Provision for income taxes
|
169
|
|
134
|
|
322
|
|
|||
Income from discontinued operations, net of tax
|
$
|
554
|
|
$
|
445
|
|
$
|
1,068
|
|
Carrying Values of AgCo and SpecCo
1
|
Dec 31, 2018
|
||
In millions
|
|||
Accounts and notes receivable - Trade
|
$
|
2,768
|
|
Accounts and notes receivable - Other
|
773
|
|
|
Inventories
|
2,826
|
|
|
Other current assets
|
151
|
|
|
Investment in nonconsolidated affiliates
|
612
|
|
|
Other investments
|
2
|
|
|
Noncurrent receivables
|
35
|
|
|
Net property
|
3,014
|
|
|
Goodwill
|
7,590
|
|
|
Other intangible assets
|
1,830
|
|
|
Deferred income tax assets
|
239
|
|
|
Deferred charges and other assets
|
60
|
|
|
Total assets of discontinued operations
|
$
|
19,900
|
|
Notes payable
|
7
|
|
|
Long-term debt due within one year
|
4
|
|
|
Accounts payable - Trade
|
1,118
|
|
|
Accounts payable - Other
|
868
|
|
|
Income taxes payable
|
234
|
|
|
Accrued and other current liabilities
|
716
|
|
|
Long-Term Debt
|
5
|
|
|
Deferred income tax liabilities
|
568
|
|
|
Pension and other postretirement benefits - noncurrent
|
306
|
|
|
Other noncurrent obligations
|
662
|
|
|
Total liabilities of discontinued operations
|
$
|
4,488
|
|
1.
|
Includes assets and liabilities of consolidated variable interest entities related to discontinued operations.
|
Net Trade Sales by Segment and Business
|
Three Months Ended
|
Six Months Ended
|
||||||||||
In millions
|
Jun 30, 2019
|
Jun 30, 2018
|
Jun 30, 2019
|
Jun 30, 2018
|
||||||||
Coatings & Performance Monomers
|
$
|
947
|
|
$
|
1,098
|
|
$
|
1,849
|
|
$
|
2,053
|
|
Consumer Solutions
|
1,409
|
|
1,526
|
|
2,789
|
|
2,898
|
|
||||
Performance Materials & Coatings
|
$
|
2,356
|
|
$
|
2,624
|
|
$
|
4,638
|
|
$
|
4,951
|
|
Industrial Solutions
|
$
|
1,070
|
|
$
|
1,214
|
|
$
|
2,197
|
|
$
|
2,389
|
|
Polyurethanes & Construction Chemicals
|
2,269
|
|
2,752
|
|
4,619
|
|
5,371
|
|
||||
Other
|
3
|
|
3
|
|
6
|
|
7
|
|
||||
Industrial Intermediates & Infrastructure
|
$
|
3,342
|
|
$
|
3,969
|
|
$
|
6,822
|
|
$
|
7,767
|
|
Hydrocarbons & Energy
|
$
|
1,349
|
|
$
|
1,879
|
|
$
|
2,753
|
|
$
|
3,707
|
|
Packaging and Specialty Plastics
|
3,856
|
|
4,245
|
|
7,590
|
|
8,455
|
|
||||
Packaging & Specialty Plastics
|
$
|
5,205
|
|
$
|
6,124
|
|
$
|
10,343
|
|
$
|
12,162
|
|
Corporate
|
$
|
111
|
|
$
|
72
|
|
$
|
180
|
|
$
|
146
|
|
Total
|
$
|
11,014
|
|
$
|
12,789
|
|
$
|
21,983
|
|
$
|
25,026
|
|
Net Trade Sales by Geographic Region
|
Three Months Ended
|
Six Months Ended
|
||||||||||
In millions
|
Jun 30, 2019
|
Jun 30, 2018
|
Jun 30, 2019
|
Jun 30, 2018
|
||||||||
U.S. & Canada
|
$
|
4,072
|
|
$
|
4,551
|
|
$
|
8,005
|
|
$
|
8,993
|
|
EMEAI
1
|
3,725
|
|
4,473
|
|
7,607
|
|
8,871
|
|
||||
Asia Pacific
|
2,170
|
|
2,480
|
|
4,271
|
|
4,668
|
|
||||
Latin America
|
1,047
|
|
1,285
|
|
2,100
|
|
2,494
|
|
||||
Total
|
$
|
11,014
|
|
$
|
12,789
|
|
$
|
21,983
|
|
$
|
25,026
|
|
Contract Assets and Liabilities
|
Jun 30, 2019
|
Dec 31, 2018
|
||||
In millions
|
||||||
Accounts and notes receivable - Trade
|
$
|
5,661
|
|
$
|
5,646
|
|
Contract assets - current
1
|
$
|
34
|
|
$
|
19
|
|
Contract assets - noncurrent
2
|
$
|
2
|
|
$
|
1
|
|
Contract liabilities - current
3
|
$
|
205
|
|
$
|
134
|
|
Contract liabilities - noncurrent
4
|
$
|
1,648
|
|
$
|
1,318
|
|
1.
|
Included in "Other current assets" in the consolidated balance sheets.
|
2.
|
Included in "Deferred charges and other assets" in the consolidated balance sheets.
|
3.
|
Included in "Accrued and other current liabilities" in the consolidated balance sheets.
|
4.
|
Included in "Other noncurrent obligations" in the consolidated balance sheets.
|
DowDuPont Synergy Program
|
Severance and Related Benefit Costs
|
Asset Write-downs and Write-offs
|
Costs Associated with Exit and Disposal Activities
|
Total
|
||||||||
In millions
|
||||||||||||
Reserve balance at Dec 31, 2017
|
$
|
270
|
|
$
|
—
|
|
$
|
5
|
|
$
|
275
|
|
Industrial Intermediates & Infrastructure
|
$
|
—
|
|
$
|
—
|
|
$
|
11
|
|
$
|
11
|
|
Packaging & Specialty Plastics
|
—
|
|
—
|
|
3
|
|
3
|
|
||||
Corporate
|
68
|
|
3
|
|
—
|
|
71
|
|
||||
Total restructuring charges
|
$
|
68
|
|
$
|
3
|
|
$
|
14
|
|
$
|
85
|
|
Charges against the reserve
|
—
|
|
(3
|
)
|
—
|
|
(3
|
)
|
||||
Cash payments
|
(48
|
)
|
—
|
|
(3
|
)
|
(51
|
)
|
||||
Reserve balance at Mar 31, 2018
|
$
|
290
|
|
$
|
—
|
|
$
|
16
|
|
$
|
306
|
|
Corporate
|
$
|
17
|
|
$
|
13
|
|
$
|
—
|
|
$
|
30
|
|
Total restructuring charges
|
$
|
17
|
|
$
|
13
|
|
$
|
—
|
|
$
|
30
|
|
Charges against the reserve
|
—
|
|
(13
|
)
|
—
|
|
(13
|
)
|
||||
Cash payments
|
(54
|
)
|
—
|
|
(6
|
)
|
(60
|
)
|
||||
Reserve balance at Jun 30, 2018
|
$
|
253
|
|
$
|
—
|
|
$
|
10
|
|
$
|
263
|
|
Packaging & Specialty Plastics
|
$
|
—
|
|
$
|
4
|
|
$
|
—
|
|
$
|
4
|
|
Corporate
|
43
|
|
—
|
|
—
|
|
43
|
|
||||
Total restructuring charges
|
$
|
43
|
|
$
|
4
|
|
$
|
—
|
|
$
|
47
|
|
Charges against the reserve
|
—
|
|
(4
|
)
|
—
|
|
(4
|
)
|
||||
Cash payments
|
(56
|
)
|
—
|
|
—
|
|
(56
|
)
|
||||
Reserve balance at Sep 30, 2018
|
$
|
240
|
|
$
|
—
|
|
$
|
10
|
|
$
|
250
|
|
Performance Materials & Coatings
|
$
|
—
|
|
$
|
7
|
|
$
|
—
|
|
$
|
7
|
|
Packaging & Specialty Plastics
|
—
|
|
6
|
|
—
|
|
6
|
|
||||
Corporate
|
9
|
|
—
|
|
—
|
|
9
|
|
||||
Total restructuring charges
|
$
|
9
|
|
$
|
13
|
|
$
|
—
|
|
$
|
22
|
|
Charges against the reserve
|
—
|
|
(13
|
)
|
—
|
|
(13
|
)
|
||||
Cash payments
|
(39
|
)
|
—
|
|
(3
|
)
|
(42
|
)
|
||||
Reserve balance at Dec 31, 2018
|
$
|
210
|
|
$
|
—
|
|
$
|
7
|
|
$
|
217
|
|
Packaging & Specialty Plastics
|
$
|
—
|
|
$
|
—
|
|
$
|
1
|
|
$
|
1
|
|
Corporate
|
52
|
|
76
|
|
15
|
|
143
|
|
||||
Total restructuring charges
|
$
|
52
|
|
$
|
76
|
|
$
|
16
|
|
$
|
144
|
|
Charges against the reserve
|
—
|
|
(76
|
)
|
—
|
|
(76
|
)
|
||||
Cash payments
|
(79
|
)
|
—
|
|
(4
|
)
|
(83
|
)
|
||||
Reserve balance at Mar 31, 2019
|
$
|
183
|
|
$
|
—
|
|
$
|
19
|
|
$
|
202
|
|
Performance Materials & Coatings
|
$
|
—
|
|
$
|
22
|
|
$
|
—
|
|
$
|
22
|
|
Corporate
|
25
|
|
7
|
|
5
|
|
37
|
|
||||
Total restructuring charges
|
$
|
25
|
|
$
|
29
|
|
$
|
5
|
|
$
|
59
|
|
Charges against the reserve
|
—
|
|
(29
|
)
|
(2
|
)
|
(31
|
)
|
||||
Cash payments
|
(71
|
)
|
—
|
|
—
|
|
(71
|
)
|
||||
Reserve balance at Jun 30, 2019
|
$
|
137
|
|
$
|
—
|
|
$
|
22
|
|
$
|
159
|
|
Net Income for Earnings Per Share Calculations
|
Three Months Ended
|
Six Months Ended
|
|||||||||||
In millions
|
Jun 30, 2019
|
Jun 30, 2018
|
Jun 30, 2019
|
Jun 30, 2018
|
|||||||||
Income from continuing operations, net of tax
|
$
|
90
|
|
$
|
810
|
|
$
|
246
|
|
$
|
1,735
|
|
|
Net income attributable to noncontrolling interests - continuing operations
|
15
|
|
25
|
|
47
|
|
46
|
|
|||||
Net income attributable to participating securities - continuing operations
1
|
2
|
|
—
|
|
2
|
|
—
|
|
|||||
Income from continuing operations attributable to common stockholders
|
$
|
73
|
|
$
|
785
|
|
$
|
197
|
|
$
|
1,689
|
|
|
Income from discontinued operations, net of tax
|
$
|
—
|
|
$
|
554
|
|
$
|
445
|
|
$
|
1,068
|
|
|
Net income attributable to noncontrolling interests - discontinued operations
|
—
|
|
6
|
|
13
|
|
20
|
|
|||||
Income from discontinued operations attributable to common stockholders
|
$
|
—
|
|
$
|
548
|
|
$
|
432
|
|
$
|
1,048
|
|
|
Net income attributable to common stockholders
|
$
|
73
|
|
$
|
1,333
|
|
$
|
629
|
|
$
|
2,737
|
|
Earnings Per Share Calculations - Basic
|
Three Months Ended
|
Six Months Ended
|
|||||||||||
Dollars per share
|
Jun 30, 2019
|
Jun 30, 2018
|
Jun 30, 2019
|
Jun 30, 2018
|
|||||||||
Income from continuing operations attributable to common stockholders
|
$
|
0.10
|
|
$
|
1.05
|
|
$
|
0.26
|
|
$
|
2.26
|
|
|
Income from discontinued operations attributable to common stockholders
|
—
|
|
0.73
|
|
0.58
|
|
1.40
|
|
|||||
Net income attributable to common stockholders
|
$
|
0.10
|
|
$
|
1.78
|
|
$
|
0.84
|
|
$
|
3.66
|
|
Earnings Per Share Calculations - Diluted
|
Three Months Ended
|
Six Months Ended
|
|||||||||||
Dollars per share
|
Jun 30, 2019
|
Jun 30, 2018
|
Jun 30, 2019
|
Jun 30, 2018
|
|||||||||
Income from continuing operations attributable to common stockholders
|
$
|
0.10
|
|
$
|
1.05
|
|
$
|
0.26
|
|
$
|
2.26
|
|
|
Income from discontinued operations attributable to common stockholders
|
—
|
|
0.73
|
|
0.58
|
|
1.40
|
|
|||||
Net income attributable to common stockholders
|
$
|
0.10
|
|
$
|
1.78
|
|
$
|
0.84
|
|
$
|
3.66
|
|
Share Count Information
|
Three Months Ended
|
Six Months Ended
|
|||||||
Shares in millions
|
Jun 30, 2019
|
Jun 30, 2018
|
Jun 30, 2019
|
Jun 30, 2018
|
|||||
Weighted-average common shares - basic
2
|
742.8
|
|
747.2
|
|
745.0
|
|
747.2
|
|
|
Plus dilutive effect of equity compensation plans
|
5.1
|
|
—
|
|
2.6
|
|
—
|
|
|
Weighted-average common shares - diluted
2
|
747.9
|
|
747.2
|
|
747.6
|
|
747.2
|
|
|
Stock options and restricted stock units excluded from EPS calculations
3
|
6.4
|
|
—
|
|
3.2
|
|
—
|
|
1.
|
Restricted stock units (formerly termed deferred stock) are considered participating securities due to the Company's practice of paying dividend equivalents on unvested shares.
|
2.
|
Share amounts for the three and six months ended June 30, 2018, were based on
2,246.3 million
DowDuPont common shares outstanding as of the Record Date for the April 1, 2019 distribution, less
4.6 million
Employee Stock Ownership Plan ("ESOP") shares that had not been released and were not considered outstanding, adjusted for the Distribution Ratio. There was no dilutive effect for the three and six months ended June 30, 2018, as the Company did not engage in activities giving rise to dilution.
|
3.
|
These outstanding options to purchase shares of common stock and restricted stock units were excluded from the calculation of diluted earnings per share because the effect of including them would have been antidilutive. For the three and six months ended June 30, 2018, the Company did not engage in activities giving rise to dilution.
|
Inventories
|
Jun 30, 2019
|
Dec 31, 2018
|
||||
In millions
|
||||||
Finished goods
|
$
|
3,988
|
|
$
|
4,313
|
|
Work in process
|
1,272
|
|
1,335
|
|
||
Raw materials
|
692
|
|
674
|
|
||
Supplies
|
837
|
|
826
|
|
||
Total
|
$
|
6,789
|
|
$
|
7,148
|
|
Adjustment of inventories to a LIFO basis
|
52
|
|
(249
|
)
|
||
Total inventories
|
$
|
6,841
|
|
$
|
6,899
|
|
Investments in Nonconsolidated Affiliates
|
Jun 30, 2019
|
Dec 31, 2018
|
||||
In millions
|
||||||
Investment in nonconsolidated affiliates
|
$
|
2,968
|
|
$
|
3,320
|
|
Other noncurrent obligations
|
(178
|
)
|
—
|
|
||
Net investment in nonconsolidated affiliates
|
$
|
2,790
|
|
$
|
3,320
|
|
Goodwill
|
Performance Materials & Coatings
|
Industrial Intermediates & Infrastructure
|
Packaging & Specialty Plastics
|
Total
|
||||||||
In millions
|
||||||||||||
Net goodwill at Dec 31, 2018
|
$
|
3,650
|
|
$
|
1,095
|
|
$
|
5,101
|
|
$
|
9,846
|
|
Foreign currency impact
|
7
|
|
(1
|
)
|
(4
|
)
|
2
|
|
||||
Net goodwill at Jun 30, 2019
|
$
|
3,657
|
|
$
|
1,094
|
|
$
|
5,097
|
|
$
|
9,848
|
|
Other Intangible Assets
|
Jun 30, 2019
|
Dec 31, 2018
|
||||||||||||||||
In millions
|
Gross
Carrying
Amount
|
Accum
Amort
|
Net
|
Gross
Carrying
Amount
|
Accum
Amort
|
Net
|
||||||||||||
Intangible assets with finite lives:
|
|
|
|
|
|
|
||||||||||||
Developed technology
|
$
|
2,634
|
|
$
|
(1,363
|
)
|
$
|
1,271
|
|
$
|
2,634
|
|
$
|
(1,252
|
)
|
$
|
1,382
|
|
Software
|
1,426
|
|
(847
|
)
|
579
|
|
1,404
|
|
(805
|
)
|
599
|
|
||||||
Trademarks/tradenames
|
352
|
|
(342
|
)
|
10
|
|
352
|
|
(329
|
)
|
23
|
|
||||||
Customer-related
|
3,242
|
|
(1,105
|
)
|
2,137
|
|
3,211
|
|
(993
|
)
|
2,218
|
|
||||||
Total other intangible assets, finite lives
|
$
|
7,654
|
|
$
|
(3,657
|
)
|
$
|
3,997
|
|
$
|
7,601
|
|
$
|
(3,379
|
)
|
$
|
4,222
|
|
In-process research and development
|
3
|
|
—
|
|
3
|
|
3
|
|
—
|
|
3
|
|
||||||
Total other intangible assets
|
$
|
7,657
|
|
$
|
(3,657
|
)
|
$
|
4,000
|
|
$
|
7,604
|
|
$
|
(3,379
|
)
|
$
|
4,225
|
|
Amortization Expense from Continuing Operations
|
Three Months Ended
|
Six Months Ended
|
||||||||||
In millions
|
Jun 30, 2019
|
Jun 30, 2018
|
Jun 30, 2019
|
Jun 30, 2018
|
||||||||
Other intangible assets, excluding software
|
$
|
104
|
|
$
|
118
|
|
$
|
220
|
|
$
|
236
|
|
Software, included in “Cost of sales” from Continuing Operations
|
$
|
23
|
|
$
|
23
|
|
$
|
47
|
|
$
|
45
|
|
Estimated Amortization Expense from Continuing Operations
|
|||
In millions
|
|||
2019
|
$
|
516
|
|
2020
|
$
|
490
|
|
2021
|
$
|
468
|
|
2022
|
$
|
406
|
|
2023
|
$
|
376
|
|
2024
|
$
|
363
|
|
Cash Proceeds
|
Three Months Ended
|
Six Months Ended
|
||||||||||
In millions
|
Jun 30,
2019 |
Jun 30,
2018 |
Jun 30,
2019 |
Jun 30,
2018 |
||||||||
Interests in conduits
1
|
$
|
—
|
|
$
|
211
|
|
$
|
—
|
|
$
|
656
|
|
1.
|
Presented in "Investing Activities" in the consolidated statements of cash flows.
|
Notes Payable
|
Jun 30,
2019 |
Dec 31,
2018 |
||||
In millions
|
||||||
Commercial paper
|
$
|
—
|
|
$
|
10
|
|
Notes payable to banks and other lenders
|
468
|
|
288
|
|
||
Notes payable to related companies
1
|
76
|
|
—
|
|
||
Total notes payable
|
$
|
544
|
|
$
|
298
|
|
Period-end average interest rates
|
5.67
|
%
|
8.28
|
%
|
1.
|
In addition, "Notes payable" for TDCC includes a
$1.1 billion
note payable to Dow Inc., which is not reflected in the table above. See Note
22
for additional information.
|
Long-Term Debt
|
2019 Average Rate
|
Jun 30,
2019 |
2018
Average
Rate
|
Dec 31,
2018 |
||||||
In millions
|
||||||||||
Promissory notes and debentures:
|
|
|
|
|
||||||
Final maturity 2019
|
9.80
|
%
|
$
|
3
|
|
9.80
|
%
|
$
|
7
|
|
Final maturity 2020
|
8.44
|
%
|
76
|
|
4.46
|
%
|
1,547
|
|
||
Final maturity 2021
|
4.71
|
%
|
1,424
|
|
4.71
|
%
|
1,424
|
|
||
Final maturity 2022
|
3.50
|
%
|
1,372
|
|
3.50
|
%
|
1,373
|
|
||
Final maturity 2023
|
7.64
|
%
|
325
|
|
7.64
|
%
|
325
|
|
||
Final maturity 2024
|
3.37
|
%
|
1,396
|
|
3.50
|
%
|
896
|
|
||
Final maturity 2025 and thereafter
|
5.70
|
%
|
9,480
|
|
5.98
|
%
|
7,963
|
|
||
Other facilities:
|
|
|
|
|
||||||
U.S. dollar loans, various rates and maturities
|
3.46
|
%
|
2,000
|
|
3.59
|
%
|
4,533
|
|
||
Foreign currency loans, various rates and maturities
|
3.38
|
%
|
619
|
|
3.20
|
%
|
708
|
|
||
Medium-term notes, varying maturities through 2025
|
3.34
|
%
|
695
|
|
3.26
|
%
|
778
|
|
||
Finance lease obligations
1
|
|
399
|
|
|
371
|
|
||||
Unamortized debt discount and issuance costs
|
|
(337
|
)
|
|
(334
|
)
|
||||
Long-term debt due within one year
2
|
|
(297
|
)
|
|
(338
|
)
|
||||
Long-term debt
|
|
$
|
17,155
|
|
|
$
|
19,253
|
|
1.
|
See Note
14
for additional information.
|
2.
|
Presented net of current portion of unamortized debt issuance costs.
|
Maturities of Long-Term Debt for Next Five Years at Jun 30, 2019
|
|||
In millions
|
|||
2019
|
$
|
148
|
|
2020
|
$
|
380
|
|
2021
1
|
$
|
3,767
|
|
2022
|
$
|
1,513
|
|
2023
|
$
|
508
|
|
2024
|
$
|
1,471
|
|
1.
|
Assumes the option to extend will be exercised for the
$2 billion
Dow Silicones Term Loan Facility.
|
Committed and Available Credit Facilities at Jun 30, 2019
|
||||||||
In millions
|
Committed Credit
|
Credit Available
|
Maturity Date
|
Interest
|
||||
Five Year Competitive Advance and Revolving Credit Facility
|
$
|
5,000
|
|
$
|
5,000
|
|
October 2023
|
Floating rate
|
Term Loan Facility
1
|
2,000
|
|
—
|
|
December 2021
|
Floating rate
|
||
North American Securitization Facility
|
800
|
|
800
|
|
September 2019
|
Floating rate
|
||
European Securitization Facility
2
|
456
|
|
456
|
|
October 2020
|
Floating rate
|
||
Bilateral Revolving Credit Facility
|
100
|
|
100
|
|
October 2019
|
Floating rate
|
||
Bilateral Revolving Credit Facility
|
100
|
|
100
|
|
March 2020
|
Floating rate
|
||
Bilateral Revolving Credit Facility
|
100
|
|
100
|
|
March 2020
|
Floating rate
|
||
Bilateral Revolving Credit Facility
|
280
|
|
280
|
|
March 2020
|
Floating rate
|
||
Bilateral Revolving Credit Facility
|
100
|
|
100
|
|
March 2020
|
Floating rate
|
||
Bilateral Revolving Credit Facility
|
200
|
|
200
|
|
March 2020
|
Floating rate
|
||
Bilateral Revolving Credit Facility
|
200
|
|
200
|
|
May 2020
|
Floating rate
|
||
Bilateral Revolving Credit Facility
|
200
|
|
200
|
|
July 2020
|
Floating rate
|
||
Bilateral Revolving Credit Facility
|
100
|
|
100
|
|
August 2020
|
Floating rate
|
||
Total committed and available credit facilities
|
$
|
9,636
|
|
$
|
7,636
|
|
|
|
1.
|
Assumes the option to extend the Dow Silicones term loan facility will be exercised.
|
2.
|
Equivalent to
Euro 400 million
.
|
Guarantees
|
Jun 30, 2019
|
Dec 31, 2018
|
||||||||||||
In millions
|
Final
Expiration
|
Maximum
Future Payments
|
Recorded
Liability
|
Final
Expiration
|
Maximum
Future Payments
|
Recorded
Liability
|
||||||||
Guarantees
|
2023
|
$
|
4,123
|
|
$
|
11
|
|
2023
|
$
|
4,273
|
|
$
|
22
|
|
Lease Cost
|
Three Months Ended
Jun 30, 2019 |
Six Months Ended Jun 30, 2019
|
||||
In millions
|
||||||
Operating lease cost
|
$
|
139
|
|
$
|
264
|
|
Finance lease cost
|
|
|
||||
Amortization of right-of-use assets - finance
|
11
|
|
17
|
|
||
Interest on lease liabilities - finance
|
7
|
|
13
|
|
||
Total finance lease cost
|
$
|
18
|
|
$
|
30
|
|
Short-term lease cost
|
50
|
|
100
|
|
||
Variable lease cost
|
63
|
|
107
|
|
||
Sublease income
|
(1
|
)
|
(2
|
)
|
||
Total lease cost
|
$
|
269
|
|
$
|
499
|
|
Other Lease Information
|
Six Months Ended Jun 30, 2019
|
||
In millions
|
|||
Cash paid for amounts included in the measurement of lease liabilities:
|
|
||
Operating cash flows from operating leases
|
$
|
269
|
|
Operating cash flows from finance leases
|
$
|
13
|
|
Financing cash flows from finance leases
|
$
|
9
|
|
Lease Position
|
Balance Sheet Classification
|
Jun 30, 2019
|
||
In millions
|
||||
Right-of-use assets obtained in exchange for lease obligations:
|
|
|
||
Operating leases
1
|
|
$
|
2,385
|
|
Finance leases
|
|
$
|
60
|
|
Assets
|
|
|
||
Operating lease assets
|
Operating lease right-of-use assets
|
$
|
2,183
|
|
Finance lease assets
|
Property
|
466
|
|
|
Finance lease amortization
|
Accumulated depreciation
|
(145
|
)
|
|
Total lease assets
|
|
$
|
2,504
|
|
Liabilities
|
|
|
||
Current
|
|
|
||
Operating
|
Operating lease liabilities - current
|
$
|
421
|
|
Finance
|
Long-term debt due within one year
|
35
|
|
|
Noncurrent
|
|
|
||
Operating
|
Operating lease liabilities - noncurrent
|
1,779
|
|
|
Finance
|
Long-Term Debt
|
364
|
|
|
Total lease liabilities
|
|
$
|
2,599
|
|
1.
|
Includes
$2.3 billion
related to the adoption of Topic 842. See Note
2
for additional information.
|
Lease Term and Discount Rate
|
Jun 30, 2019
|
|
Weighted-average remaining lease term
|
|
|
Operating leases
|
8.2 years
|
|
Finance leases
|
11.7 years
|
|
Weighted-average discount rate
|
|
|
Operating leases
|
4.21
|
%
|
Finance leases
|
6.72
|
%
|
Maturities of Lease Liabilities at Jun 30, 2019
|
Operating Leases
|
Finance Leases
|
||||
In millions
|
||||||
2019
|
$
|
291
|
|
$
|
40
|
|
2020
|
510
|
|
70
|
|
||
2021
|
401
|
|
69
|
|
||
2022
|
346
|
|
52
|
|
||
2023
|
259
|
|
79
|
|
||
2024 and thereafter
|
979
|
|
308
|
|
||
Total future undiscounted lease payments
|
$
|
2,786
|
|
$
|
618
|
|
Less imputed interest
|
586
|
|
219
|
|
||
Total present value of lease liabilities
|
$
|
2,200
|
|
$
|
399
|
|
Minimum Lease Commitments at Dec 31, 2018
|
|
||
In millions
|
|
||
2019
|
$
|
366
|
|
2020
|
329
|
|
|
2021
|
296
|
|
|
2022
|
269
|
|
|
2023
|
227
|
|
|
2024 and thereafter
|
855
|
|
|
Total
|
$
|
2,342
|
|
Lease Guarantees
|
Jun 30, 2019
|
Dec 31, 2018
|
||||||||||||
In millions
|
Final Expiration
|
Maximum Future Payments
|
Recorded Liability
|
Final Expiration
|
Maximum Future Payments
|
Recorded Liability
|
||||||||
Residual value guarantees
|
2027
|
$
|
755
|
|
$
|
—
|
|
2028
|
$
|
885
|
|
$
|
130
|
|
Shares of Dow Inc. Common Stock
|
Issued
|
Held in Treasury
|
||
|
||||
Balance at Jan 1, 2019
|
100
|
|
—
|
|
Impact of recapitalization
|
748,771,140
|
|
—
|
|
Issued
1
|
254,522
|
|
—
|
|
Repurchased
|
—
|
|
5,813,756
|
|
Balance at Jun 30, 2019
|
749,025,762
|
|
5,813,756
|
|
1.
|
Shares issued to employees under the Company's equity compensation plans.
|
Accumulated Other Comprehensive Loss
|
Three Months Ended
|
Six Months Ended
|
||||||||||
In millions
|
Jun 30, 2019
|
Jun 30, 2018
|
Jun 30, 2019
|
Jun 30, 2018
|
||||||||
Unrealized Gains (Losses) on Investments
|
|
|
|
|
||||||||
Beginning balance
|
$
|
16
|
|
$
|
(8
|
)
|
$
|
(51
|
)
|
$
|
17
|
|
Unrealized gains (losses) on investments
|
52
|
|
(18
|
)
|
138
|
|
(49
|
)
|
||||
Less: Tax (expense) benefit
|
(11
|
)
|
3
|
|
(29
|
)
|
8
|
|
||||
Net unrealized gains (losses) on investments
|
41
|
|
(15
|
)
|
109
|
|
(41
|
)
|
||||
(Gains) losses reclassified from AOCL to net income
1
|
(11
|
)
|
1
|
|
(12
|
)
|
3
|
|
||||
Less: Tax expense (benefit)
2
|
3
|
|
—
|
|
3
|
|
(1
|
)
|
||||
Net (gains) losses reclassified from AOCL to net income
|
(8
|
)
|
1
|
|
(9
|
)
|
2
|
|
||||
Other comprehensive income (loss), net of tax
|
33
|
|
(14
|
)
|
100
|
|
(39
|
)
|
||||
Reclassification of stranded tax effects
3
|
—
|
|
(1
|
)
|
—
|
|
(1
|
)
|
||||
Ending balance
|
$
|
49
|
|
$
|
(23
|
)
|
$
|
49
|
|
$
|
(23
|
)
|
Cumulative Translation Adjustment
|
|
|
|
|
||||||||
Beginning balance
|
$
|
(1,844
|
)
|
$
|
(1,105
|
)
|
$
|
(1,813
|
)
|
$
|
(1,481
|
)
|
Gains (losses) on foreign currency translation
|
76
|
|
(443
|
)
|
64
|
|
(72
|
)
|
||||
Less: Tax (expense) benefit
|
15
|
|
(25
|
)
|
14
|
|
(20
|
)
|
||||
Net gains (losses) on foreign currency translation
|
91
|
|
(468
|
)
|
78
|
|
(92
|
)
|
||||
(Gains) losses reclassified from AOCL to net income
4
|
(24
|
)
|
(2
|
)
|
(42
|
)
|
(2
|
)
|
||||
Other comprehensive income (loss), net of tax
|
67
|
|
(470
|
)
|
36
|
|
(94
|
)
|
||||
Impact of common control transaction
5
|
710
|
|
—
|
|
710
|
|
—
|
|
||||
Reclassification of stranded tax effects
3
|
—
|
|
(107
|
)
|
—
|
|
(107
|
)
|
||||
Ending balance
|
$
|
(1,067
|
)
|
$
|
(1,682
|
)
|
$
|
(1,067
|
)
|
$
|
(1,682
|
)
|
Pension and Other Postretirement Benefits
|
|
|
|
|
||||||||
Beginning balance
|
$
|
(7,824
|
)
|
$
|
(6,872
|
)
|
$
|
(7,965
|
)
|
$
|
(6,998
|
)
|
Gains (losses) arising during the period
|
34
|
|
—
|
|
34
|
|
—
|
|
||||
Less: Tax (expense) benefit
|
(10
|
)
|
—
|
|
(10
|
)
|
—
|
|
||||
Net gains (losses) arising during the period
|
24
|
|
—
|
|
24
|
|
—
|
|
||||
Amortization and recognition of net loss and prior service credits
6
|
108
|
|
158
|
|
274
|
|
312
|
|
||||
Less: Tax expense (benefit)
2
|
(26
|
)
|
(34
|
)
|
(51
|
)
|
(62
|
)
|
||||
Net loss and prior service credits reclassified from AOCL to net income
|
82
|
|
124
|
|
223
|
|
250
|
|
||||
Other comprehensive income (loss), net of tax
|
106
|
|
124
|
|
247
|
|
250
|
|
||||
Impact of common control transaction
5
|
83
|
|
—
|
|
83
|
|
—
|
|
||||
Reclassification of stranded tax effects
3
|
—
|
|
(927
|
)
|
—
|
|
(927
|
)
|
||||
Ending balance
|
$
|
(7,635
|
)
|
$
|
(7,675
|
)
|
$
|
(7,635
|
)
|
$
|
(7,675
|
)
|
Derivative Instruments
|
|
|
|
|
||||||||
Beginning balance
|
$
|
(131
|
)
|
$
|
(103
|
)
|
$
|
(56
|
)
|
$
|
(109
|
)
|
Gains (losses) on derivative instruments
|
(263
|
)
|
108
|
|
(358
|
)
|
94
|
|
||||
Less: Tax (expense) benefit
|
46
|
|
(17
|
)
|
73
|
|
(19
|
)
|
||||
Net gains (losses) on derivative instruments
|
(217
|
)
|
91
|
|
(285
|
)
|
75
|
|
||||
(Gains) losses reclassified from AOCL to net income
7
|
17
|
|
32
|
|
10
|
|
59
|
|
||||
Less: Tax expense (benefit)
2
|
(4
|
)
|
(5
|
)
|
(4
|
)
|
(10
|
)
|
||||
Net (gains) losses reclassified from AOCL to net income
|
13
|
|
27
|
|
6
|
|
49
|
|
||||
Other comprehensive income (loss), net of tax
|
(204
|
)
|
118
|
|
(279
|
)
|
124
|
|
||||
Reclassification of stranded tax effects
3
|
—
|
|
(22
|
)
|
—
|
|
(22
|
)
|
||||
Ending balance
|
$
|
(335
|
)
|
$
|
(7
|
)
|
$
|
(335
|
)
|
$
|
(7
|
)
|
Total AOCL ending balance
|
$
|
(8,988
|
)
|
$
|
(9,387
|
)
|
$
|
(8,988
|
)
|
$
|
(9,387
|
)
|
1.
|
Reclassified to "Net sales" and "Sundry income (expense) - net."
|
2.
|
Reclassified to "Provision for income taxes."
|
3.
|
Amounts reclassified to "Retained earnings" as a result of the adoption of ASU 2018-02.
|
4.
|
Reclassified to "Sundry income (expense) - net."
|
5.
|
Reclassified to "Retained earnings" as a result of the separation from DowDuPont on April 1, 2019. See Note
3
for additional information.
|
Noncontrolling Interests
|
Three Months Ended
|
Six Months Ended
|
||||||||||
In millions
|
Jun 30, 2019
|
Jun 30, 2018
|
Jun 30, 2019
|
Jun 30, 2018
|
||||||||
Balance at beginning of period
|
$
|
1,180
|
|
$
|
1,190
|
|
$
|
1,138
|
|
$
|
1,186
|
|
Net income attributable to noncontrolling interests - continuing operations
|
15
|
|
25
|
|
47
|
|
46
|
|
||||
Net income attributable to noncontrolling interests - discontinued operations
|
—
|
|
6
|
|
13
|
|
20
|
|
||||
Distributions to noncontrolling interests
1
|
(5
|
)
|
(37
|
)
|
(14
|
)
|
(61
|
)
|
||||
Impact of common control transaction
2
|
(353
|
)
|
—
|
|
(353
|
)
|
—
|
|
||||
Purchase of noncontrolling interest
3
|
(254
|
)
|
—
|
|
(254
|
)
|
—
|
|
||||
Cumulative translation adjustments
|
6
|
|
(34
|
)
|
13
|
|
(40
|
)
|
||||
Other
|
—
|
|
2
|
|
(1
|
)
|
1
|
|
||||
Balance at end of period
|
$
|
589
|
|
$
|
1,152
|
|
$
|
589
|
|
$
|
1,152
|
|
2.
|
Relates to the separation from DowDuPont. See Note
3
for additional information.
|
3.
|
Relates to the pending acquisition of full ownership in a propylene oxide manufacturing joint venture, which is expected to occur in the fourth quarter of 2019. See Note
21
for additional information. As a result of this arrangement, the carrying value of the noncontrolling interest was removed, a liability of
$283 million
was recognized, and “Additional paid-in capital” was adjusted by
$29 million
. After adjustment for subsequent dividends of
$127 million
, paid to the noncontrolling interest holder in the second quarter of 2019, the liability at June 30, 2019 was
$156 million
and is reflected in “Accrued and other current liabilities” in the consolidated balance sheets.
|
Net Periodic Benefit Cost for All Significant Plans
|
Three Months Ended
|
Six Months Ended
|
||||||||||
In millions
|
Jun 30,
2019 |
Jun 30,
2018 |
Jun 30,
2019 |
Jun 30,
2018 |
||||||||
Defined Benefit Pension Plans:
|
|
|
|
|
||||||||
Service cost
|
$
|
95
|
|
$
|
132
|
|
$
|
207
|
|
$
|
265
|
|
Interest cost
|
227
|
|
217
|
|
468
|
|
435
|
|
||||
Expected return on plan assets
|
(421
|
)
|
(404
|
)
|
(838
|
)
|
(810
|
)
|
||||
Amortization of prior service credit
|
(5
|
)
|
(6
|
)
|
(11
|
)
|
(12
|
)
|
||||
Amortization of net loss
|
147
|
|
170
|
|
279
|
|
341
|
|
||||
Curtailment/special termination benefits
1
|
(27
|
)
|
—
|
|
(27
|
)
|
—
|
|
||||
Net periodic benefit cost
|
$
|
16
|
|
$
|
109
|
|
$
|
78
|
|
$
|
219
|
|
Less: discontinued operations
|
—
|
|
25
|
|
21
|
|
50
|
|
||||
Net periodic benefit cost - continuing operations
|
$
|
16
|
|
$
|
84
|
|
$
|
57
|
|
$
|
169
|
|
|
|
|
|
|
||||||||
Other Postretirement Benefits:
|
|
|
|
|
||||||||
Service cost
|
$
|
2
|
|
$
|
3
|
|
$
|
4
|
|
$
|
6
|
|
Interest cost
|
12
|
|
11
|
|
26
|
|
22
|
|
||||
Amortization of net gain
|
(5
|
)
|
(6
|
)
|
(11
|
)
|
(12
|
)
|
||||
Curtailment/special termination benefits
1
|
(3
|
)
|
—
|
|
(3
|
)
|
—
|
|
||||
Net periodic benefit cost
|
$
|
6
|
|
$
|
8
|
|
$
|
16
|
|
$
|
16
|
|
Less: discontinued operations
|
—
|
|
1
|
|
—
|
|
2
|
|
||||
Net periodic benefit cost - continuing operations
|
$
|
6
|
|
$
|
7
|
|
$
|
16
|
|
$
|
14
|
|
1.
|
The 2019 impact relates to plan curtailments and associated special termination benefits resulting from the reduction in plan participation by employees transferred to DowDuPont.
|
•
|
1.6 million
stock options with a weighted-average exercise price of
$54.89
and a weighted-average fair value of
$7.99
per share;
|
•
|
1.8 million
RSUs with a weighted-average fair value of
$54.85
per share; and
|
•
|
1.2 million
PSUs with a weighted-average fair value of
$57.58
per share.
|
Fair Value of Financial Instruments
|
Jun 30, 2019
|
Dec 31, 2018
|
||||||||||||||||||||||
In millions
|
Cost
|
Gain
|
Loss
|
Fair Value
|
Cost
|
Gain
|
Loss
|
Fair Value
|
||||||||||||||||
Cash equivalents
|
$
|
530
|
|
$
|
—
|
|
$
|
—
|
|
$
|
530
|
|
$
|
566
|
|
$
|
—
|
|
$
|
—
|
|
$
|
566
|
|
Marketable securities
|
$
|
20
|
|
$
|
—
|
|
$
|
—
|
|
$
|
20
|
|
$
|
100
|
|
$
|
—
|
|
$
|
—
|
|
$
|
100
|
|
Other investments:
|
|
|
|
|
|
|
|
|
||||||||||||||||
Debt securities:
|
|
|
|
|
|
|
|
|
||||||||||||||||
Government debt
1
|
$
|
540
|
|
$
|
28
|
|
$
|
(5
|
)
|
$
|
563
|
|
$
|
714
|
|
$
|
9
|
|
$
|
(23
|
)
|
$
|
700
|
|
Corporate bonds
|
1,054
|
|
63
|
|
(13
|
)
|
1,104
|
|
1,026
|
|
20
|
|
(63
|
)
|
983
|
|
||||||||
Total debt securities
|
$
|
1,594
|
|
$
|
91
|
|
$
|
(18
|
)
|
$
|
1,667
|
|
$
|
1,740
|
|
$
|
29
|
|
$
|
(86
|
)
|
$
|
1,683
|
|
Equity securities
2
|
15
|
|
7
|
|
(1
|
)
|
21
|
|
16
|
|
1
|
|
(1
|
)
|
16
|
|
||||||||
Total other investments
|
$
|
1,609
|
|
$
|
98
|
|
$
|
(19
|
)
|
$
|
1,688
|
|
$
|
1,756
|
|
$
|
30
|
|
$
|
(87
|
)
|
$
|
1,699
|
|
Total cash equivalents, marketable securities and other investments
|
$
|
2,159
|
|
$
|
98
|
|
$
|
(19
|
)
|
$
|
2,238
|
|
$
|
2,422
|
|
$
|
30
|
|
$
|
(87
|
)
|
$
|
2,365
|
|
Long-term debt including debt due within one year
3
|
$
|
(17,452
|
)
|
$
|
2
|
|
$
|
(1,922
|
)
|
$
|
(19,372
|
)
|
$
|
(19,591
|
)
|
$
|
351
|
|
$
|
(972
|
)
|
$
|
(20,212
|
)
|
Derivatives relating to:
|
|
|
|
|
|
|
|
|
||||||||||||||||
Interest rates
4
|
$
|
—
|
|
$
|
11
|
|
$
|
(225
|
)
|
$
|
(214
|
)
|
$
|
—
|
|
$
|
—
|
|
$
|
(64
|
)
|
$
|
(64
|
)
|
Foreign currency
|
—
|
|
52
|
|
(38
|
)
|
14
|
|
—
|
|
120
|
|
(43
|
)
|
77
|
|
||||||||
Commodities
4
|
—
|
|
84
|
|
(170
|
)
|
(86
|
)
|
—
|
|
91
|
|
(178
|
)
|
(87
|
)
|
||||||||
Total derivatives
|
$
|
—
|
|
$
|
147
|
|
$
|
(433
|
)
|
$
|
(286
|
)
|
$
|
—
|
|
$
|
211
|
|
$
|
(285
|
)
|
$
|
(74
|
)
|
2.
|
Equity securities with a readily determinable fair value.
|
3.
|
Cost includes fair value hedge adjustments of
$1 million
at
June 30, 2019
and
$18 million
at
December 31, 2018
on
$2,590 million
of debt at
June 30, 2019
and
$2,290 million
of debt at
December 31, 2018
.
|
4.
|
Presented net of cash collateral where master netting arrangements allow.
|
Investing Results
|
Six Months Ended
|
|||||
In millions
|
Jun 30,
2019 |
Jun 30,
2018 |
||||
Proceeds from sales of available-for-sale securities
|
$
|
534
|
|
$
|
625
|
|
Gross realized gains
|
$
|
22
|
|
$
|
15
|
|
Gross realized losses
|
$
|
(10
|
)
|
$
|
(18
|
)
|
Fair Value of Derivative Instruments
|
Jun 30, 2019
|
|||||||||
In millions
|
Balance Sheet Classification
|
Gross
|
Counterparty and Cash Collateral Netting
1
|
Net Amounts Included in the Consolidated Balance Sheet
|
||||||
Asset derivatives:
|
|
|
|
|
||||||
Derivatives designated as hedging instruments:
|
|
|
|
|
||||||
Interest rate contracts
|
Other current assets
|
$
|
11
|
|
$
|
—
|
|
$
|
11
|
|
Foreign currency contracts
|
Other current assets
|
104
|
|
(85
|
)
|
19
|
|
|||
Commodity contracts
|
Other current assets
|
53
|
|
(17
|
)
|
36
|
|
|||
Commodity contracts
|
Deferred charges and other assets
|
42
|
|
(7
|
)
|
35
|
|
|||
Total
|
|
$
|
210
|
|
$
|
(109
|
)
|
$
|
101
|
|
Derivatives not designated as hedging instruments:
|
|
|
|
|
||||||
Interest rate contracts
|
Other current assets
|
$
|
1
|
|
$
|
(1
|
)
|
$
|
—
|
|
Foreign currency contracts
|
Other current assets
|
44
|
|
(11
|
)
|
33
|
|
|||
Commodity contracts
|
Other current assets
|
14
|
|
(4
|
)
|
10
|
|
|||
Commodity contracts
|
Deferred charges and other assets
|
4
|
|
(1
|
)
|
3
|
|
|||
Total
|
|
$
|
63
|
|
$
|
(17
|
)
|
$
|
46
|
|
Total asset derivatives
|
|
$
|
273
|
|
$
|
(126
|
)
|
$
|
147
|
|
|
|
|
|
|
||||||
Liability derivatives:
|
|
|
|
|
||||||
Derivatives designated as hedging instruments:
|
|
|
|
|
||||||
Interest rate contracts
|
Accrued and other current liabilities
|
$
|
98
|
|
$
|
—
|
|
$
|
98
|
|
Interest rate contracts
|
Other noncurrent obligations
|
127
|
|
—
|
|
127
|
|
|||
Foreign currency contracts
|
Accrued and other current liabilities
|
116
|
|
(85
|
)
|
31
|
|
|||
Commodity contracts
|
Accrued and other current liabilities
|
117
|
|
(20
|
)
|
97
|
|
|||
Commodity contracts
|
Other noncurrent obligations
|
57
|
|
(12
|
)
|
45
|
|
|||
Total
|
|
$
|
515
|
|
$
|
(117
|
)
|
$
|
398
|
|
Derivatives not designated as hedging instruments:
|
|
|
|
|
||||||
Interest rate contracts
|
Accrued and other current liabilities
|
$
|
2
|
|
$
|
(2
|
)
|
$
|
—
|
|
Foreign currency contracts
|
Accrued and other current liabilities
|
18
|
|
(11
|
)
|
7
|
|
|||
Commodity contracts
|
Accrued and other current liabilities
|
31
|
|
(6
|
)
|
25
|
|
|||
Commodity contracts
|
Other noncurrent obligations
|
4
|
|
(1
|
)
|
3
|
|
|||
Total
|
|
$
|
55
|
|
$
|
(20
|
)
|
$
|
35
|
|
Total liability derivatives
|
|
$
|
570
|
|
$
|
(137
|
)
|
$
|
433
|
|
1.
|
Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the Company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty.
|
Fair Value of Derivative Instruments
|
Dec 31, 2018
|
|||||||||
In millions
|
Balance Sheet Classification
|
Gross
|
Counterparty and Cash Collateral Netting
1
|
Net Amounts Included in the Consolidated Balance Sheet
|
||||||
Asset derivatives:
|
|
|
|
|
||||||
Derivatives designated as hedging instruments:
|
|
|
|
|
||||||
Foreign currency contracts
|
Other current assets
|
$
|
98
|
|
$
|
(42
|
)
|
$
|
56
|
|
Commodity contracts
|
Other current assets
|
47
|
|
(13
|
)
|
34
|
|
|||
Commodity contracts
|
Deferred charges and other assets
|
18
|
|
(3
|
)
|
15
|
|
|||
Total
|
|
$
|
163
|
|
$
|
(58
|
)
|
$
|
105
|
|
Derivatives not designated as hedging instruments:
|
|
|
|
|
||||||
Foreign currency contracts
|
Other current assets
|
$
|
128
|
|
$
|
(64
|
)
|
$
|
64
|
|
Commodity contracts
|
Other current assets
|
41
|
|
(1
|
)
|
40
|
|
|||
Commodity contracts
|
Deferred charges and other assets
|
4
|
|
(2
|
)
|
2
|
|
|||
Total
|
|
$
|
173
|
|
$
|
(67
|
)
|
$
|
106
|
|
Total asset derivatives
|
|
$
|
336
|
|
$
|
(125
|
)
|
$
|
211
|
|
|
|
|
|
|
||||||
Liability derivatives:
|
|
|
|
|
||||||
Derivatives designated as hedging instruments:
|
|
|
|
|
||||||
Interest rate swaps
|
Other noncurrent obligations
|
$
|
64
|
|
$
|
—
|
|
$
|
64
|
|
Foreign currency contracts
|
Accrued and other current liabilities
|
46
|
|
(42
|
)
|
4
|
|
|||
Commodity contracts
|
Accrued and other current liabilities
|
111
|
|
(18
|
)
|
93
|
|
|||
Commodity contracts
|
Other noncurrent obligations
|
86
|
|
(9
|
)
|
77
|
|
|||
Total
|
|
$
|
307
|
|
$
|
(69
|
)
|
$
|
238
|
|
Derivatives not designated as hedging instruments:
|
|
|
|
|
||||||
Foreign currency contracts
|
Accrued and other current liabilities
|
$
|
103
|
|
$
|
(64
|
)
|
$
|
39
|
|
Commodity contracts
|
Accrued and other current liabilities
|
7
|
|
(4
|
)
|
3
|
|
|||
Commodity contracts
|
Other noncurrent obligations
|
8
|
|
(3
|
)
|
5
|
|
|||
Total
|
|
$
|
118
|
|
$
|
(71
|
)
|
$
|
47
|
|
Total liability derivatives
|
|
$
|
425
|
|
$
|
(140
|
)
|
$
|
285
|
|
1.
|
Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the Company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty.
|
Basis of Fair Value Measurements on a Recurring Basis
|
Jun 30, 2019
|
Dec 31, 2018
|
||||||||||||||||
Quoted Prices in Active Markets for Identical Items
(Level 1) |
Significant Other Observable Inputs
(Level 2) |
Total
|
Quoted Prices in Active Markets for Identical Items
(Level 1) |
Significant Other Observable Inputs
(Level 2) |
Total
|
|||||||||||||
In millions
|
||||||||||||||||||
Assets at fair value:
|
|
|
|
|
|
|
||||||||||||
Cash equivalents
1
|
$
|
—
|
|
$
|
530
|
|
$
|
530
|
|
$
|
—
|
|
$
|
566
|
|
$
|
566
|
|
Marketable securities
|
—
|
|
20
|
|
20
|
|
—
|
|
100
|
|
100
|
|
||||||
Equity securities
2
|
21
|
|
—
|
|
21
|
|
16
|
|
—
|
|
16
|
|
||||||
Debt securities:
2
|
|
|
|
|
|
|
||||||||||||
Government debt
3
|
—
|
|
563
|
|
563
|
|
—
|
|
700
|
|
700
|
|
||||||
Corporate bonds
|
22
|
|
1,082
|
|
1,104
|
|
—
|
|
983
|
|
983
|
|
||||||
Derivatives relating to:
4
|
|
|
|
|
|
|
||||||||||||
Interest rates
|
—
|
|
12
|
|
12
|
|
—
|
|
—
|
|
—
|
|
||||||
Foreign currency
|
—
|
|
148
|
|
148
|
|
—
|
|
226
|
|
226
|
|
||||||
Commodities
|
15
|
|
98
|
|
113
|
|
17
|
|
93
|
|
110
|
|
||||||
Total assets at fair value
|
$
|
58
|
|
$
|
2,453
|
|
$
|
2,511
|
|
$
|
33
|
|
$
|
2,668
|
|
$
|
2,701
|
|
Liabilities at fair value:
|
|
|
|
|
|
|
||||||||||||
Long-term debt including debt due within one year
5
|
$
|
—
|
|
$
|
19,372
|
|
$
|
19,372
|
|
$
|
—
|
|
$
|
20,212
|
|
$
|
20,212
|
|
Derivatives relating to:
4
|
|
|
|
|
|
|
||||||||||||
Interest rates
|
—
|
|
227
|
|
227
|
|
—
|
|
64
|
|
64
|
|
||||||
Foreign currency
|
—
|
|
134
|
|
134
|
|
—
|
|
149
|
|
149
|
|
||||||
Commodities
|
18
|
|
191
|
|
209
|
|
23
|
|
189
|
|
212
|
|
||||||
Total liabilities at fair value
|
$
|
18
|
|
$
|
19,924
|
|
$
|
19,942
|
|
$
|
23
|
|
$
|
20,614
|
|
$
|
20,637
|
|
1.
|
Treasury bills, time deposits, and money market funds included in "Cash and cash equivalents" in the consolidated balance sheets and held at amortized cost, which approximates fair value.
|
2.
|
The Company’s investments in debt securities, which are primarily available-for-sale, and equity securities are included in “Other investments” in the consolidated balance sheets.
|
3.
|
U.S. Treasury obligations, U.S. agency obligations, agency mortgage-backed securities and other municipalities’ obligations.
|
4.
|
See Note
19
for the classification of derivatives in the consolidated balance sheets.
|
5.
|
See Note
19
for information on fair value measurements of long-term debt.
|
Assets and Liabilities of Consolidated VIEs
|
Jun 30,
2019 |
Dec 31,
2018 |
||||
In millions
|
||||||
Cash and cash equivalents
|
$
|
26
|
|
$
|
71
|
|
Other current assets
|
101
|
|
101
|
|
||
Net property
|
657
|
|
683
|
|
||
Other noncurrent assets
|
23
|
|
14
|
|
||
Total assets
1
|
$
|
807
|
|
$
|
869
|
|
Current liabilities
|
$
|
436
|
|
$
|
307
|
|
Long-term debt
|
45
|
|
75
|
|
||
Other noncurrent obligations
|
22
|
|
14
|
|
||
Total liabilities
2
|
$
|
503
|
|
$
|
396
|
|
1.
|
All assets were restricted at
June 30, 2019
and
December 31, 2018
.
|
2.
|
All liabilities were nonrecourse at
June 30, 2019
and
December 31, 2018
.
|
Carrying Amounts of Assets Related to Nonconsolidated VIEs
|
|
Jun 30,
2019 |
Dec 31,
2018 |
||||
In millions
|
Description of asset
|
||||||
Silicon joint ventures
|
Equity method investments
1
|
$
|
98
|
|
$
|
100
|
|
AgroFresh Solutions, Inc.
|
Equity method investment
1
|
$
|
31
|
|
$
|
48
|
|
Other receivable
2
|
$
|
8
|
|
$
|
8
|
|
1.
|
Classified as "Investment in nonconsolidated affiliates" in the consolidated balance sheets.
|
2.
|
Classified as "Accounts and notes receivable - Other" in the consolidated balance sheets.
|
Balances Due To or Due From Historical DuPont and its Affiliates
|
Jun 30, 2019
|
Dec 31, 2018
|
||||
In millions
|
||||||
Accounts and notes receivable - Other
|
$
|
—
|
|
$
|
89
|
|
Accounts payable - Other
|
$
|
—
|
|
$
|
19
|
|
Sales to Historical DuPont and its Affiliates
|
Three Months Ended
|
Six Months Ended
|
||||||||||
In millions
|
Jun 30, 2019
|
Jun 30, 2018
|
Jun 30, 2019
|
Jun 30, 2018
|
||||||||
Net sales
|
$
|
—
|
|
$
|
13
|
|
$
|
12
|
|
$
|
25
|
|
Cost of sales
|
$
|
—
|
|
$
|
11
|
|
$
|
9
|
|
$
|
20
|
|
•
|
EQUATE - a Kuwait-based company that manufactures ethylene, polyethylene and ethylene glycol, and manufactures and markets monoethylene glycol, diethylene glycol and polyethylene terephthalate resins; owned
42.5 percent
by the Company.
|
•
|
The Kuwait Olefins Company K.S.C.C. (“TKOC”) - a Kuwait-based company that manufactures ethylene and ethylene glycol; owned
42.5 percent
by the Company.
|
•
|
Map Ta Phut Olefins Company Limited ("Map Ta Phut") - a Thailand-based company that manufactures propylene and ethylene; the Company has an effective ownership of
32.77 percent
(of which
20.27 percent
is owned directly by the Company and aligned with the Industrial Intermediates & Infrastructure segment and
12.5 percent
is owned indirectly through the Company’s equity interest in Siam Polyethylene Company Limited, an entity that is part of The SCG-Dow Group and aligned with the Packaging & Specialty Plastics segment).
|
•
|
Sadara - a Saudi Arabian company that manufactures chlorine, ethylene, propylene and aromatics for internal consumption and manufactures and sells polyethylene, ethylene oxide and propylene oxide derivative products, and isocyanates; owned
35 percent
by the Company.
|
•
|
The Kuwait Styrene Company K.S.C.C. - a Kuwait-based company that manufactures styrene monomer; owned
42.5 percent
by the Company.
|
•
|
The SCG-Dow Group - a group of Thailand-based companies (consisting of Siam Polyethylene Company Limited; Siam Polystyrene Company Limited; Siam Styrene Monomer Co., Ltd.; and Siam Synthetic Latex Company Limited) that manufacture polyethylene, polystyrene, styrene, latex and specialty elastomers; owned
50 percent
by the Company.
|
Segment Information
|
Perf. Materials & Coatings
|
Ind. Interm. & Infrast.
|
Pack. & Spec. Plastics
|
Corp.
|
Total
|
||||||||||
In millions
|
|||||||||||||||
Three months ended Jun 30, 2019
|
|
|
|
|
|
||||||||||
Net sales
|
$
|
2,356
|
|
$
|
3,342
|
|
$
|
5,205
|
|
$
|
111
|
|
$
|
11,014
|
|
Equity in earnings (losses) of nonconsolidated affiliates
|
1
|
|
(78
|
)
|
74
|
|
(12
|
)
|
(15
|
)
|
|||||
Dow Inc. Operating EBIT
1
|
214
|
|
154
|
|
768
|
|
(77
|
)
|
1,059
|
|
|||||
Three months ended Jun 30, 2018
|
|
|
|
|
|
|
|
|
|
|
|||||
Net sales
|
$
|
2,624
|
|
$
|
3,969
|
|
$
|
6,124
|
|
$
|
72
|
|
$
|
12,789
|
|
Pro forma net sales
|
2,673
|
|
3,972
|
|
6,134
|
|
72
|
|
12,851
|
|
|||||
Equity in earnings (losses) of nonconsolidated affiliates
|
1
|
|
96
|
|
108
|
|
(12
|
)
|
193
|
|
|||||
Pro forma Operating EBIT
|
292
|
|
502
|
|
926
|
|
(81
|
)
|
1,639
|
|
|||||
Six months ended Jun 30, 2019
|
|
|
|
|
|
|
|
|
|
|
|||||
Net sales
|
$
|
4,638
|
|
$
|
6,822
|
|
$
|
10,343
|
|
$
|
180
|
|
$
|
21,983
|
|
Pro forma net sales
|
4,676
|
|
6,831
|
|
10,343
|
|
180
|
|
22,030
|
|
|||||
Equity in earnings (losses) of nonconsolidated affiliates
|
1
|
|
(126
|
)
|
112
|
|
(16
|
)
|
(29
|
)
|
|||||
Dow Inc. pro forma Operating EBIT
2
|
485
|
|
431
|
|
1,458
|
|
(172
|
)
|
2,202
|
|
|||||
Six months ended Jun 30, 2018
|
|
|
|
|
|
|
|
|
|
|
|||||
Net sales
|
$
|
4,951
|
|
$
|
7,767
|
|
$
|
12,162
|
|
$
|
146
|
|
$
|
25,026
|
|
Pro forma net sales
|
5,044
|
|
7,775
|
|
12,182
|
|
146
|
|
25,147
|
|
|||||
Equity in earnings (losses) of nonconsolidated affiliates
|
1
|
|
245
|
|
167
|
|
(19
|
)
|
394
|
|
|||||
Pro forma Operating EBIT
|
647
|
|
962
|
|
1,897
|
|
(170
|
)
|
3,336
|
|
1.
|
Operating EBIT for TDCC for the three months ended June 30, 2019 is substantially the same as that of Dow Inc. and therefore has not been disclosed separately in the table above. A reconciliation of "Income from continuing operations, net of tax" to Operating EBIT is provided below.
|
2.
|
Pro forma Operating EBIT for TDCC for the six months ended June 30, 2019 is substantially the same as that of Dow Inc. (same for the three and six months ended June 30, 2018) and therefore has not been disclosed separately in the table above. A reconciliation of "Income from continuing operations, net of tax" to pro forma Operating EBIT is provided below.
|
Reconciliation of "Income from continuing operations, net of tax" to Operating EBIT
|
Three Months Ended
|
||
In millions
|
Jun 30, 2019
|
||
Income from continuing operations, net of tax
|
$
|
90
|
|
+ Provision for income taxes on continuing operations
|
125
|
|
|
Income from continuing operations before income taxes
|
$
|
215
|
|
- Interest income
|
21
|
|
|
+ Interest expense and amortization of debt discount
|
237
|
|
|
- Significant items
|
(628
|
)
|
|
Operating EBIT
|
$
|
1,059
|
|
Reconciliation of "Income from continuing operations, net of tax" to Pro Forma Operating EBIT
|
Three Months Ended
|
Six Months Ended
|
|||||||
In millions
|
Jun 30, 2018
|
Jun 30, 2019
|
Jun 30, 2018
|
||||||
Income from continuing operations, net of tax
|
$
|
810
|
|
$
|
246
|
|
$
|
1,735
|
|
+ Provision for income taxes on continuing operations
|
249
|
|
266
|
|
475
|
|
|||
Income from continuing operations before income taxes
|
$
|
1,059
|
|
$
|
512
|
|
$
|
2,210
|
|
- Interest income
|
18
|
|
39
|
|
38
|
|
|||
+ Interest expense and amortization of debt discount
|
261
|
|
478
|
|
523
|
|
|||
+ Pro forma adjustments
1
|
51
|
|
65
|
|
96
|
|
|||
- Significant items
|
(286
|
)
|
(1,186
|
)
|
(545
|
)
|
|||
Pro forma Operating EBIT
|
$
|
1,639
|
|
$
|
2,202
|
|
$
|
3,336
|
|
1.
|
Pro forma adjustments include (1) the margin impact of various manufacturing, supply and service related agreements entered into with DuPont and Corteva in connection with the separation which provide for different pricing than the historical intercompany and intracompany pricing practices of TDCC and Historical DuPont, (2) the removal of the amortization of ECP's inventory step-up recognized in connection with the Merger, and (3) the elimination of the impact of events directly attributable to the Merger, internal reorganization and business realignment, separation, distribution and other related transactions (e.g., one-time transaction costs).
|
Significant Items by Segment
|
Three Months Ended Jun 30, 2019
|
Six Months Ended Jun 30, 2019
|
||||||||||||||||||||||||||||
Perf. Mat. & Coatings
|
Ind. Interm. & Infrast.
|
Pack. & Spec. Plastics
|
Corp.
|
Total
|
Perf. Mat. & Coatings
|
Ind. Interm. & Infrast.
|
Pack. & Spec. Plastics
|
Corp.
|
Total
|
|||||||||||||||||||||
In millions
|
||||||||||||||||||||||||||||||
Indemnification and other transaction related costs
1
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
$
|
(127
|
)
|
$
|
(127
|
)
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
$
|
(127
|
)
|
$
|
(127
|
)
|
Integration and separation costs
2
|
—
|
|
—
|
|
—
|
|
(348
|
)
|
(348
|
)
|
—
|
|
—
|
|
—
|
|
(750
|
)
|
(750
|
)
|
||||||||||
Restructuring and asset related charges - net
3
|
(22
|
)
|
—
|
|
(6
|
)
|
(37
|
)
|
(65
|
)
|
(22
|
)
|
—
|
|
(19
|
)
|
(180
|
)
|
(221
|
)
|
||||||||||
Loss on divestiture
4
|
—
|
|
—
|
|
—
|
|
(44
|
)
|
(44
|
)
|
—
|
|
—
|
|
—
|
|
(44
|
)
|
(44
|
)
|
||||||||||
Loss on early extinguishment of debt
5
|
—
|
|
—
|
|
—
|
|
(44
|
)
|
(44
|
)
|
—
|
|
—
|
|
—
|
|
(44
|
)
|
(44
|
)
|
||||||||||
Total
|
$
|
(22
|
)
|
$
|
—
|
|
$
|
(6
|
)
|
$
|
(600
|
)
|
$
|
(628
|
)
|
$
|
(22
|
)
|
$
|
—
|
|
$
|
(19
|
)
|
$
|
(1,145
|
)
|
$
|
(1,186
|
)
|
1.
|
Includes charges primarily associated with agreements entered into with DuPont and Corteva as part of the separation and distribution which, among other matters, provides for cross-indemnities and allocations of obligations and liabilities for periods prior to, at and after the completion of the separation.
|
2.
|
Costs related to post-Merger integration and business separation activities. The six months ended June 30, 2019 excludes one-time transaction costs directly attributable to the Merger.
|
3.
|
Includes Board approved restructuring plans and asset-related charges, which includes other asset impairments. See Note 5 for additional information.
|
4.
|
Includes post-closing adjustments on a previous divestiture.
|
5.
|
The Company retired outstanding long-term debt resulting in a loss on early extinguishment. See Note 12 for additional information.
|
Significant Items by Segment
|
Three Months Ended Jun 30, 2018
|
Six Months Ended Jun 30, 2018
|
||||||||||||||||||||||||||||
Perf. Mat. & Coatings
|
Ind. Interm. & Infrast.
|
Pack. & Spec. Plastics
|
Corp.
|
Total
|
Perf. Mat. & Coatings
|
Ind. Interm. & Infrast.
|
Pack. & Spec. Plastics
|
Corp.
|
Total
|
|||||||||||||||||||||
In millions
|
||||||||||||||||||||||||||||||
Impact of Dow Silicones ownership restructure
1
|
$
|
(20
|
)
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
$
|
(20
|
)
|
$
|
(20
|
)
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
$
|
(20
|
)
|
Integration and separation costs
2
|
—
|
|
—
|
|
—
|
|
(234
|
)
|
(234
|
)
|
—
|
|
—
|
|
—
|
|
(441
|
)
|
(441
|
)
|
||||||||||
Restructuring and asset related charges - net
3
|
(15
|
)
|
—
|
|
(3
|
)
|
(14
|
)
|
(32
|
)
|
(14
|
)
|
(11
|
)
|
(9
|
)
|
(70
|
)
|
(104
|
)
|
||||||||||
Gain on divestiture
4
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
20
|
|
—
|
|
—
|
|
20
|
|
||||||||||
Total
|
$
|
(35
|
)
|
$
|
—
|
|
$
|
(3
|
)
|
$
|
(248
|
)
|
$
|
(286
|
)
|
$
|
(34
|
)
|
$
|
9
|
|
$
|
(9
|
)
|
$
|
(511
|
)
|
$
|
(545
|
)
|
1.
|
Includes a loss related to a post-closing adjustment related to the Dow Silicones ownership restructure.
|
2.
|
Costs related to post-Merger integration and business separation activities, and costs related to the ownership restructure of Dow Silicones. Excludes one-time transaction costs directly attributable to the Merger.
|
3.
|
Includes Board approved restructuring plans and asset related charges, which include other asset impairments. See Note 5 for additional information. Excludes one-time transaction costs directly attributable to the Merger.
|
4.
|
Includes a gain related to the Company's sale of its equity interest in MEGlobal.
|
•
|
The Company reported net sales in the second quarter of 2019 of $11.0 billion, down 14 percent from $12.8 billion in the second quarter of 2018, with declines across all geographic regions and segments. These declines were due to a decrease in local price of 9 percent, a volume decline of 4 percent and a 2 percent unfavorable currency impact which were partially offset by a 1 percent increase in Portfolio & Other.
|
•
|
Local price decreased 9 percent compared with the same period last year, with decreases in all segments, including a double-digit decline in Industrial Intermediates & Infrastructure (down 12 percent). Local price decreased in all geographic regions, including double-digit declines in Latin America (down 15 percent) and U.S. & Canada and Asia Pacific (both down 10 percent).
|
•
|
Volume decreased 4 percent compared with the second quarter of 2018, with decreases in all operating segments: Performance Materials & Coatings (down 7 percent), Packaging & Specialty Plastics (down 4 percent) and Industrial Intermediates & Infrastructure (down 2 percent). Volume decreased in Europe, Middle East, Africa and India ("EMEAI") (down 6 percent), Latin America (down 4 percent) and U.S. & Canada (down 3 percent). Volume was flat in Asia Pacific.
|
•
|
Currency had an unfavorable impact of 2 percent on net sales, driven primarily by EMEAI (down 5 percent).
|
•
|
Portfolio & Other increased 1 percent as a result of the sales impact of various manufacturing, supply and service related agreements entered into with DuPont and Corteva in connection with the separation, impacting Performance Materials & Coatings.
|
•
|
Research and development ("R&D") expenses were $208 million in the second quarter of 2019, down from $221 million in the second quarter of 2018. Selling, general and administrative ("SG&A") expenses for Dow Inc. and TDCC were $422 million and $418 million, respectively, in the second quarter of 2019, down from $485 million in the second quarter of 2018. R&D and SG&A expenses decreased primarily due to cost reductions and lower performance-based compensation costs.
|
•
|
Restructuring and asset related charges - net were $65 million in the second quarter of 2019, primarily reflecting post-merger restructuring actions under the DowDuPont Cost Synergy Program.
|
•
|
Integration and separation costs for Dow Inc. and TDCC were $348 million and $324 million, respectively, in the second quarter of 2019, up from $262 million in the second quarter of 2018, reflecting post-Merger integration and business separation activities.
|
•
|
Equity in earnings (losses) of nonconsolidated affiliates was a loss of $15 million in the second quarter of 2019, down from earnings of $193 million in the second quarter of 2018, primarily due to increased equity losses from Sadara and lower equity earnings from the Kuwait joint ventures and the Thai joint ventures.
|
•
|
Sundry income (expense) - net for Dow Inc. and TDCC were an expense of $1 million and income of $109 million, respectively, in the second quarter of 2019, compared with expense of $14 million in the second quarter of 2018. Sundry income (expense) - net increased for TDCC primarily due to an increase in foreign currency exchange gains and non-operating pension and postretirement benefit plan credits compared with the second quarter of 2018. In addition to the items discussed for TDCC, Dow Inc. incurred a loss on post-closing adjustments related to a previous divestiture and charges associated with agreements entered into with DuPont and Corteva as part of the separation and distribution.
|
•
|
Net income available for Dow Inc. and TDCC common stockholder(s) was $75 million and $202 million, respectively, in the second quarter of 2019, compared with $1,333 million in the second quarter of 2018. Earnings per share for Dow Inc. was $0.10 per share in the second quarter of 2019, compared with $1.78 per share in the second quarter of 2018.
|
•
|
On April 11, 2019, Dow Inc. announced that its Board of Directors declared a dividend of $0.70 per share, paid on June 14, 2019, to shareholders of record on May 31, 2019.
|
•
|
In May 2019, the Company issued
$2.0 billion
of senior unsecured notes in an offering under Rule 144A of the Securities Act of 1933. In June 2019, the Company redeemed
$1.5 billion
of
4.25 percent
notes issued by the Company with maturity in 2020. In addition, in April and June of 2019, the Company voluntarily repaid $2.0 billion and $500 million, respectively, of principal on the Dow Silicones Term Loan Facility.
|
•
|
Dow Inc. repurchased $305 million of the Company's common stock in the second quarter of 2019. Dow Inc. remains on track to repurchase an additional $200 million of the Company's common stock in the second half of 2019 to reach its full-year target of approximately $500 million of repurchases.
|
•
|
On July 25, 2019, the Company announced that after a detailed analysis of project returns and future demand growth, it has decided to postpone construction of the planned 450 KTA polyolefins facility in Europe.
|
Selected Financial Data - Dow Inc.
|
Three Months Ended
|
Six Months Ended
|
||||||||||
In millions
|
Jun 30,
2019 |
Jun 30,
2018 |
Jun 30,
2019 |
Jun 30,
2018 |
||||||||
Net sales
|
$
|
11,014
|
|
$
|
12,789
|
|
$
|
21,983
|
|
$
|
25,026
|
|
|
|
|
|
|
||||||||
Cost of sales ("COS")
|
$
|
9,420
|
|
$
|
10,540
|
|
$
|
18,562
|
|
$
|
20,520
|
|
Percent of net sales
|
85.5
|
%
|
82.4
|
%
|
84.4
|
%
|
82.0
|
%
|
||||
|
|
|
|
|
||||||||
R&D
|
$
|
208
|
|
$
|
221
|
|
$
|
398
|
|
$
|
429
|
|
Percent of net sales
|
1.9
|
%
|
1.7
|
%
|
1.8
|
%
|
1.7
|
%
|
||||
|
|
|
|
|
||||||||
SG&A
|
$
|
422
|
|
$
|
485
|
|
$
|
870
|
|
$
|
967
|
|
Percent of net sales
|
3.8
|
%
|
3.8
|
%
|
4.0
|
%
|
3.9
|
%
|
||||
|
|
|
|
|
||||||||
Effective tax rate
|
58.1
|
%
|
23.5
|
%
|
52.0
|
%
|
21.5
|
%
|
||||
|
|
|
|
|
||||||||
Net income available for common stockholders
|
$
|
75
|
|
$
|
1,333
|
|
$
|
631
|
|
$
|
2,737
|
|
Selected Financial Data - TDCC
|
Three Months Ended
|
Six Months Ended
|
||||||||||
In millions
|
Jun 30,
2019 |
Jun 30,
2018 |
Jun 30,
2019 |
Jun 30,
2018 |
||||||||
Net sales
|
$
|
11,014
|
|
$
|
12,789
|
|
$
|
21,983
|
|
$
|
25,026
|
|
|
|
|
|
|
||||||||
COS
|
$
|
9,419
|
|
$
|
10,540
|
|
$
|
18,561
|
|
$
|
20,520
|
|
Percent of net sales
|
85.5
|
%
|
82.4
|
%
|
84.4
|
%
|
82.0
|
%
|
||||
|
|
|
|
|
||||||||
R&D
|
$
|
208
|
|
$
|
221
|
|
$
|
398
|
|
$
|
429
|
|
Percent of net sales
|
1.9
|
%
|
1.7
|
%
|
1.8
|
%
|
1.7
|
%
|
||||
|
|
|
|
|
||||||||
SG&A
|
$
|
418
|
|
$
|
485
|
|
$
|
866
|
|
$
|
967
|
|
Percent of net sales
|
3.8
|
%
|
3.8
|
%
|
3.9
|
%
|
3.9
|
%
|
||||
|
|
|
|
|
||||||||
Effective tax rate
|
36.5
|
%
|
23.5
|
%
|
41.6
|
%
|
21.5
|
%
|
||||
|
|
|
|
|
||||||||
Net income available for the common stockholder
|
$
|
202
|
|
$
|
1,333
|
|
$
|
758
|
|
$
|
2,737
|
|
Summary of Sales Results
|
Three Months Ended
|
Six Months Ended
|
||||||||||
In millions
|
Jun 30, 2019
|
Jun 30, 2018
|
Jun 30, 2019
|
Jun 30, 2018
|
||||||||
Net sales
|
$
|
11,014
|
|
$
|
12,789
|
|
$
|
21,983
|
|
$
|
25,026
|
|
Pro forma net sales
|
|
$
|
12,851
|
|
$
|
22,030
|
|
$
|
25,147
|
|
Sales Variances by Segment and Geographic Region - As Reported
|
||||||||||||||||||||
|
Three Months Ended Jun 30, 2019
|
Six Months Ended Jun 30, 2019
|
||||||||||||||||||
Local Price & Product Mix
|
Currency
|
Volume
|
Portfolio & Other
1
|
Total
|
Local Price & Product Mix
|
Currency
|
Volume
|
Portfolio & Other
1
|
Total
|
|||||||||||
Percentage change from prior year
|
||||||||||||||||||||
Performance Materials & Coatings
|
(4
|
)%
|
(2
|
)%
|
(7
|
)%
|
3
|
%
|
(10
|
)%
|
(3
|
)%
|
(2
|
)%
|
(3
|
)%
|
2
|
%
|
(6
|
)%
|
Industrial Intermediates & Infrastructure
|
(12
|
)
|
(2
|
)
|
(2
|
)
|
—
|
|
(16
|
)
|
(12
|
)
|
(2
|
)
|
2
|
|
—
|
|
(12
|
)
|
Packaging & Specialty Plastics
|
(9
|
)
|
(2
|
)
|
(4
|
)
|
—
|
|
(15
|
)
|
(10
|
)
|
(2
|
)
|
(3
|
)
|
—
|
|
(15
|
)
|
Total
|
(9
|
)%
|
(2
|
)%
|
(4
|
)%
|
1
|
%
|
(14
|
)%
|
(9
|
)%
|
(2
|
)%
|
(1
|
)%
|
—
|
%
|
(12
|
)%
|
U.S. & Canada
|
(10
|
)%
|
—
|
%
|
(3
|
)%
|
2
|
%
|
(11
|
)%
|
(8
|
)%
|
—
|
%
|
(4
|
)%
|
1
|
%
|
(11
|
)%
|
EMEAI
|
(6
|
)
|
(5
|
)
|
(6
|
)
|
—
|
|
(17
|
)
|
(7
|
)
|
(5
|
)
|
(2
|
)
|
—
|
|
(14
|
)
|
Asia Pacific
|
(10
|
)
|
(2
|
)
|
—
|
|
—
|
|
(12
|
)
|
(11
|
)
|
(2
|
)
|
4
|
|
—
|
|
(9
|
)
|
Latin America
|
(15
|
)
|
—
|
|
(4
|
)
|
—
|
|
(19
|
)
|
(14
|
)
|
—
|
|
(2
|
)
|
—
|
|
(16
|
)
|
Total
|
(9
|
)%
|
(2
|
)%
|
(4
|
)%
|
1
|
%
|
(14
|
)%
|
(9
|
)%
|
(2
|
)%
|
(1
|
)%
|
—
|
%
|
(12
|
)%
|
1.
|
Portfolio & Other includes the sales impact of various manufacturing, supply and service related agreements entered into with DuPont and Corteva in connection with the separation which provide for different pricing than the historical intercompany and intracompany pricing practices of TDCC and Historical DuPont.
|
Sales Variances by Segment and Geographic Region - Pro Forma Basis
|
||||||||||||||||||||
|
Three Months Ended Jun 30, 2019
|
Six Months Ended Jun 30, 2019
|
||||||||||||||||||
Local Price & Product Mix
|
Currency
|
Volume
|
Portfolio & Other
|
Total
|
Local Price & Product Mix
|
Currency
|
Volume
|
Portfolio & Other
1
|
Total
|
|||||||||||
Percentage change from prior year
|
||||||||||||||||||||
Performance Materials & Coatings
|
(5
|
)%
|
(2
|
)%
|
(5
|
)%
|
—
|
%
|
(12
|
)%
|
(3
|
)%
|
(2
|
)%
|
(2
|
)%
|
—
|
%
|
(7
|
)%
|
Industrial Intermediates & Infrastructure
|
(12
|
)
|
(3
|
)
|
(1
|
)
|
—
|
|
(16
|
)
|
(12
|
)
|
(3
|
)
|
3
|
|
—
|
|
(12
|
)
|
Packaging & Specialty Plastics
|
(9
|
)
|
(2
|
)
|
(4
|
)
|
—
|
|
(15
|
)
|
(10
|
)
|
(2
|
)
|
(3
|
)
|
—
|
|
(15
|
)
|
Total
|
(9
|
)%
|
(2
|
)%
|
(3
|
)%
|
—
|
%
|
(14
|
)%
|
(9
|
)%
|
(2
|
)%
|
(1
|
)%
|
—
|
%
|
(12
|
)%
|
U.S. & Canada
|
(9
|
)%
|
—
|
%
|
(2
|
)%
|
—
|
%
|
(11
|
)%
|
(8
|
)%
|
—
|
%
|
(3
|
)%
|
(1
|
)%
|
(12
|
)%
|
EMEAI
|
(6
|
)
|
(5
|
)
|
(6
|
)
|
—
|
|
(17
|
)
|
(7
|
)
|
(5
|
)
|
(2
|
)
|
—
|
|
(14
|
)
|
Asia Pacific
|
(11
|
)
|
(2
|
)
|
—
|
|
—
|
|
(13
|
)
|
(11
|
)
|
(2
|
)
|
4
|
|
—
|
|
(9
|
)
|
Latin America
|
(15
|
)
|
—
|
|
(4
|
)
|
—
|
|
(19
|
)
|
(14
|
)
|
—
|
|
(2
|
)
|
—
|
|
(16
|
)
|
Total
|
(9
|
)%
|
(2
|
)%
|
(3
|
)%
|
—
|
%
|
(14
|
)%
|
(9
|
)%
|
(2
|
)%
|
(1
|
)%
|
—
|
%
|
(12
|
)%
|
1.
|
Portfolio & Other includes the sales impact of various manufacturing, supply and service related agreements entered into with DuPont and Corteva in connection with the separation which provide for different pricing than the historical intercompany and intracompany pricing practices of TDCC and Historical DuPont.
|
Performance Materials & Coatings
|
Three Months Ended
|
Six Months Ended
|
||||||||||
In millions
|
Jun 30, 2019
|
Jun 30, 2018
|
Jun 30, 2019
|
Jun 30, 2018
|
||||||||
Net sales
|
$
|
2,356
|
|
$
|
2,624
|
|
$
|
4,638
|
|
$
|
4,951
|
|
Pro forma net sales
|
|
$
|
2,673
|
|
$
|
4,676
|
|
$
|
5,044
|
|
||
Operating EBIT
|
$
|
214
|
|
|
|
|
||||||
Pro forma Operating EBIT
|
|
$
|
292
|
|
$
|
485
|
|
$
|
647
|
|
||
Equity earnings
|
$
|
1
|
|
$
|
1
|
|
$
|
1
|
|
$
|
1
|
|
Performance Materials & Coatings
|
Three Months Ended
|
Six Months Ended
|
||
Percentage change from prior year
|
Jun 30, 2019
|
Jun 30, 2019
|
||
Change in Net Sales from Prior Period due to:
|
|
|
||
Local price & product mix
|
(4
|
)%
|
(3
|
)%
|
Currency
|
(2
|
)
|
(2
|
)
|
Volume
|
(7
|
)
|
(3
|
)
|
Portfolio & other
|
3
|
|
2
|
|
Total
|
(10
|
)%
|
(6
|
)%
|
Change in Pro Forma Net Sales from Prior Period due to:
1
|
|
|
||
Local price & product mix
|
(5
|
)%
|
(3
|
)%
|
Currency
|
(2
|
)
|
(2
|
)
|
Volume
|
(5
|
)
|
(2
|
)
|
Portfolio & other
|
—
|
|
—
|
|
Total
|
(12
|
)%
|
(7
|
)%
|
1.
|
As reported net sales for the three months ended June 30, 2019 compared with pro forma net sales for the three months ended June 30, 2018.
|
Industrial Intermediates & Infrastructure
|
Three Months Ended
|
Six Months Ended
|
||||||||||
In millions
|
Jun 30, 2019
|
Jun 30, 2018
|
Jun 30, 2019
|
Jun 30, 2018
|
||||||||
Net sales
|
$
|
3,342
|
|
$
|
3,969
|
|
$
|
6,822
|
|
$
|
7,767
|
|
Pro forma net sales
|
|
$
|
3,972
|
|
$
|
6,831
|
|
$
|
7,775
|
|
||
Operating EBIT
|
$
|
154
|
|
|
|
|
||||||
Pro forma Operating EBIT
|
|
$
|
502
|
|
$
|
431
|
|
$
|
962
|
|
||
Equity earnings (losses)
|
$
|
(78
|
)
|
$
|
96
|
|
$
|
(126
|
)
|
$
|
245
|
|
Industrial Intermediates & Infrastructure
|
Three Months Ended
|
Six Months Ended
|
||
Percentage change from prior year
|
Jun 30, 2019
|
Jun 30, 2019
|
||
Change in Net Sales from Prior Period due to:
|
|
|
||
Local price & product mix
|
(12
|
)%
|
(12
|
)%
|
Currency
|
(2
|
)
|
(2
|
)
|
Volume
|
(2
|
)
|
2
|
|
Portfolio & other
|
—
|
|
—
|
|
Total
|
(16
|
)%
|
(12
|
)%
|
Change in Pro Forma Net Sales from Prior Period due to:
1
|
|
|
||
Local price & product mix
|
(12
|
)%
|
(12
|
)%
|
Currency
|
(3
|
)
|
(3
|
)
|
Volume
|
(1
|
)
|
3
|
|
Portfolio & other
|
—
|
|
—
|
|
Total
|
(16
|
)%
|
(12
|
)%
|
1.
|
As reported net sales for the three months ended June 30, 2019 compared with pro forma net sales for the three months ended June 30, 2018.
|
Packaging & Specialty Plastics
|
Three Months Ended
|
Six Months Ended
|
||||||||||
In millions
|
Jun 30, 2019
|
Jun 30, 2018
|
Jun 30, 2019
|
Jun 30, 2018
|
||||||||
Net sales
|
$
|
5,205
|
|
$
|
6,124
|
|
$
|
10,343
|
|
$
|
12,162
|
|
Pro forma net sales
|
|
$
|
6,134
|
|
$
|
10,343
|
|
$
|
12,182
|
|
||
Operating EBIT
|
$
|
768
|
|
|
|
|
||||||
Pro forma Operating EBIT
|
|
$
|
926
|
|
$
|
1,458
|
|
$
|
1,897
|
|
||
Equity earnings
|
$
|
74
|
|
$
|
108
|
|
$
|
112
|
|
$
|
167
|
|
Packaging & Specialty Plastics
|
Three Months Ended
|
Six Months Ended
|
||
Percentage change from prior year
|
Jun 30, 2019
|
Jun 30, 2019
|
||
Change in Net Sales from Prior Period due to:
|
|
|
||
Local price & product mix
|
(9
|
)%
|
(10
|
)%
|
Currency
|
(2
|
)
|
(2
|
)
|
Volume
|
(4
|
)
|
(3
|
)
|
Portfolio & other
|
—
|
|
—
|
|
Total
|
(15
|
)%
|
(15
|
)%
|
Change in Pro Forma Net Sales from Prior Period due to:
1
|
|
|
||
Local price & product mix
|
(9
|
)%
|
(10
|
)%
|
Currency
|
(2
|
)
|
(2
|
)
|
Volume
|
(4
|
)
|
(3
|
)
|
Portfolio & other
|
—
|
|
—
|
|
Total
|
(15
|
)%
|
(15
|
)%
|
1.
|
As reported net sales for the three months ended June 30, 2019 compared with pro forma net sales for the three months ended June 30, 2018.
|
Corporate
|
Three Months Ended
|
Six Months Ended
|
||||||||||
In millions
|
Jun 30, 2019
|
Jun 30, 2018
|
Jun 30, 2019
|
Jun 30, 2018
|
||||||||
Net sales
|
$
|
111
|
|
$
|
72
|
|
$
|
180
|
|
$
|
146
|
|
Pro forma net sales
|
|
$
|
72
|
|
$
|
180
|
|
$
|
146
|
|
||
Operating EBIT
|
$
|
(77
|
)
|
|
|
|
||||||
Pro forma Operating EBIT
|
|
$
|
(81
|
)
|
$
|
(172
|
)
|
$
|
(170
|
)
|
||
Equity losses
|
$
|
(12
|
)
|
$
|
(12
|
)
|
$
|
(16
|
)
|
$
|
(19
|
)
|
Cash Flow Summary
|
Dow Inc.
|
TDCC
|
||||||||||
|
Six Months Ended
|
Six Months Ended
|
||||||||||
|
Jun 30, 2019
|
Jun 30, 2018
|
Jun 30, 2019
|
Jun 30, 2018
|
||||||||
In millions
|
||||||||||||
Cash provided by (used for):
|
|
|
|
|
||||||||
Operating activities - continuing operations
|
$
|
2,003
|
|
$
|
1,504
|
|
$
|
1,977
|
|
$
|
1,504
|
|
Operating activities - discontinued operations
|
253
|
|
289
|
|
346
|
|
289
|
|
||||
Operating activities
|
2,256
|
|
1,793
|
|
2,323
|
|
1,793
|
|
||||
Investing activities - continuing operations
|
(846
|
)
|
(340
|
)
|
(846
|
)
|
(340
|
)
|
||||
Investing activities - discontinued operations
|
(34
|
)
|
(112
|
)
|
(34
|
)
|
(112
|
)
|
||||
Investing activities
|
(880
|
)
|
(452
|
)
|
(880
|
)
|
(452
|
)
|
||||
Financing activities - continuing operations
|
(1,649
|
)
|
(2,569
|
)
|
(1,716
|
)
|
(2,569
|
)
|
||||
Financing activities - discontinued operations
|
(18
|
)
|
(43
|
)
|
(18
|
)
|
(43
|
)
|
||||
Financing activities
|
(1,667
|
)
|
(2,612
|
)
|
(1,734
|
)
|
(2,612
|
)
|
||||
Effect of exchange rate changes on cash, cash equivalents and restricted cash
|
10
|
|
(69
|
)
|
10
|
|
(69
|
)
|
||||
Summary
|
|
|
|
|
||||||||
Decrease in cash, cash equivalents and restricted cash
|
(281
|
)
|
(1,340
|
)
|
(281
|
)
|
(1,340
|
)
|
||||
Cash, cash equivalents and restricted cash at beginning of year
|
2,764
|
|
6,208
|
|
2,764
|
|
6,208
|
|
||||
Cash, cash equivalents and restricted cash at end of year
|
$
|
2,483
|
|
$
|
4,868
|
|
$
|
2,483
|
|
$
|
4,868
|
|
Less: Restricted cash and cash equivalents, included in "Other current assets"
|
37
|
|
45
|
|
37
|
|
45
|
|
||||
Cash and cash equivalents at end of year
|
$
|
2,446
|
|
$
|
4,823
|
|
$
|
2,446
|
|
$
|
4,823
|
|
Net Working Capital
|
Dow Inc.
|
TDCC
|
||||||||||
|
Jun 30, 2019
|
Dec 31, 2018
|
Jun 30, 2019
|
Dec 31, 2018
|
||||||||
In millions
|
||||||||||||
Current assets
1
|
$
|
18,637
|
|
$
|
19,470
|
|
$
|
18,468
|
|
$
|
19,470
|
|
Current liabilities
1
|
11,605
|
|
11,059
|
|
12,217
|
|
11,059
|
|
||||
Net working capital
|
$
|
7,032
|
|
$
|
8,411
|
|
$
|
6,251
|
|
$
|
8,411
|
|
Current ratio
|
1.61:1
|
|
1.76:1
|
|
1.51:1
|
|
1.76:1
|
|
1.
|
Amounts at December 31, 2018, exclude assets and liabilities of discontinued operations.
|
Working Capital Metrics
|
Three Months Ended
|
|||
|
Jun 30, 2019
|
Jun 30, 2018
|
||
|
||||
Days sales outstanding in receivables
1
|
47
|
|
44
|
|
Days sales in inventory
2
|
67
|
|
60
|
|
Days payables outstanding
|
63
|
|
64
|
|
1.
|
The increase in days sales outstanding in receivables (“DSO”) was primarily due to an increase in accounts receivable as a result of the Company’s accounts receivable securitization facilities moving from off-balance sheet arrangements to secured borrowing arrangements in the second half of 2018.
|
2.
|
The increase in days sales in inventory is primarily due to a decrease in COS for the three months ended June 30, 2019 compared with the three months ended June 30, 2018.
|
Reconciliation of Non-GAAP Measures
|
Dow Inc.
|
TDCC
|
||||||||||
|
Jun 30, 2019
|
Jun 30, 2018
|
Jun 30, 2019
|
Jun 30, 2018
|
||||||||
In millions
|
||||||||||||
Cash provided by operating activities - continuing operations (GAAP)
|
$
|
2,003
|
|
$
|
1,504
|
|
$
|
1,977
|
|
$
|
1,504
|
|
Impact of ASU 2016-15 and related interpretive guidance
|
—
|
|
656
|
|
—
|
|
656
|
|
||||
Cash flows from operating activities - continuing operations - excluding impact of ASU 2016-15 (Non-GAAP)
|
$
|
2,003
|
|
$
|
2,160
|
|
$
|
1,977
|
|
$
|
2,160
|
|
Capital expenditures
|
(912
|
)
|
(868
|
)
|
(912
|
)
|
(868
|
)
|
||||
Free cash flow (Non-GAAP)
|
$
|
1,091
|
|
$
|
1,292
|
|
$
|
1,065
|
|
$
|
1,292
|
|
Total Debt
|
Dow Inc.
|
TDCC
|
||||||||||
|
Jun 30, 2019
|
Dec 31, 2018
|
Jun 30, 2019
|
Dec 31, 2018
|
||||||||
In millions
|
||||||||||||
Notes payable
|
$
|
544
|
|
$
|
298
|
|
$
|
1,691
|
|
$
|
298
|
|
Long-term debt due within one year
|
297
|
|
338
|
|
297
|
|
338
|
|
||||
Long-term debt
|
17,155
|
|
19,253
|
|
17,155
|
|
19,253
|
|
||||
Gross debt
|
$
|
17,996
|
|
$
|
19,889
|
|
$
|
19,143
|
|
$
|
19,889
|
|
- Cash and cash equivalents
|
2,446
|
|
2,724
|
|
2,446
|
|
2,724
|
|
||||
- Marketable securities
|
20
|
|
100
|
|
20
|
|
100
|
|
||||
Net debt
|
$
|
15,530
|
|
$
|
17,065
|
|
$
|
16,677
|
|
$
|
17,065
|
|
Gross debt as a percent of total capitalization
|
49.3
|
%
|
37.2
|
%
|
51.2
|
%
|
37.2
|
%
|
||||
Net debt as a percent of total capitalization
|
45.6
|
%
|
33.7
|
%
|
47.7
|
%
|
33.7
|
%
|
Credit Ratings
|
Long-Term Rating
|
Short-Term Rating
|
Outlook
|
Standard & Poor’s
|
BBB
|
A-2
|
Stable
|
Moody’s Investors Service
|
Baa2
|
P-2
|
Stable
|
Fitch Ratings
|
BBB+
|
F2
|
Stable
|
Contractual Obligations at Jun 30, 2019
|
Payments Due In
|
|
|||||||||||||
In millions
|
2019
|
2020-2021
|
2022-2023
|
2024 and beyond
|
Total
|
||||||||||
Dow Inc. and TDCC
|
|
|
|
|
|
||||||||||
Long-term debt obligations
1
|
$
|
148
|
|
$
|
4,147
|
|
$
|
2,021
|
|
$
|
11,473
|
|
$
|
17,789
|
|
Expected cash requirements for interest
2
|
$
|
435
|
|
$
|
1,688
|
|
$
|
1,321
|
|
$
|
7,886
|
|
$
|
11,330
|
|
Operating leases
|
$
|
291
|
|
$
|
911
|
|
$
|
605
|
|
$
|
979
|
|
$
|
2,786
|
|
Purchase obligations
3
|
$
|
2,902
|
|
$
|
4,572
|
|
$
|
3,707
|
|
$
|
5,853
|
|
$
|
17,034
|
|
Dow Inc.
|
|
|
|
|
|
||||||||||
Other noncurrent obligations
4
|
$
|
—
|
|
$
|
1,205
|
|
$
|
634
|
|
$
|
1,303
|
|
$
|
3,142
|
|
TDCC
|
|
|
|
|
|
||||||||||
Other noncurrent obligations
4
|
$
|
—
|
|
$
|
877
|
|
$
|
599
|
|
$
|
1,140
|
|
$
|
2,616
|
|
1.
|
Excludes unamortized debt discount and issuance costs of $337 million. Includes finance lease obligations of $399 million. Assumes the option to extend will be exercised for
$2 billion
of the Dow Silicones Term Loan Facility.
|
2.
|
Cash requirements for interest on long-term debt was calculated using current interest rates at June 30, 2019, and includes $2,367 million of various floating rate notes.
|
3.
|
Includes outstanding purchase orders and other commitments greater than $1 million obtained through a survey conducted within the Company.
|
4.
|
Includes liabilities related to asbestos litigation, environmental remediation, legal settlements, obligations with DuPont and Corteva and other noncurrent liabilities. The table excludes uncertain tax positions due to uncertainties in the timing of the effective settlement of tax positions with the respective taxing authorities and deferred tax liabilities as it is impractical to determine whether there will be a cash impact related to these liabilities. The table also excludes deferred revenue as it does not represent future cash requirements arising from contractual payment obligations.
|
Asbestos-Related Claim Activity
|
2019
|
2018
|
||
Claims unresolved at Jan 1
|
12,780
|
|
15,427
|
|
Claims filed
|
2,819
|
|
3,537
|
|
Claims settled, dismissed or otherwise resolved
|
(3,477
|
)
|
(5,230
|
)
|
Claims unresolved at Jun 30
|
12,122
|
|
13,734
|
|
Claimants with claims against both Union Carbide and Amchem
|
(4,217
|
)
|
(4,928
|
)
|
Individual claimants at Jun 30
|
7,905
|
|
8,806
|
|
Dow Inc. and Subsidiaries
The Dow Chemical Company and Subsidiaries
PART II – OTHER INFORMATION
|
Issuer Purchases of Equity Securities
|
Total number of shares purchased as part of the Company's publicly announced share repurchase program
|
Approximate dollar value of shares that may yet be purchased under the Company's publicly announced share repurchase program
1
(In millions)
|
||||||||
Period
|
Total number of shares purchased
|
Average price paid per share
|
||||||||
April 2019
|
—
|
|
$
|
—
|
|
—
|
|
$
|
3,000
|
|
May 2019
|
5,813,756
|
|
$
|
52.54
|
|
5,813,756
|
|
$
|
2,695
|
|
June 2019
|
—
|
|
$
|
—
|
|
—
|
|
$
|
2,695
|
|
Second quarter 2019
|
5,813,756
|
|
$
|
52.54
|
|
5,813,756
|
|
$
|
2,695
|
|
1.
|
On April 1, 2019, Dow Inc.'s Board of Directors ratified the share repurchase program originally approved on March 15, 2019, authorizing up to $3.0 billion to be spent on the repurchase of the Company's common stock, with no expiration date.
|
|
EXHIBIT NO.
|
|
DESCRIPTION
|
|
|
Separation and Distribution Agreement, dated as of April 1, 2019, by and among Corteva, Inc., Dow Inc. and DowDuPont Inc. (incorporated by reference to Exhibit 2.1 to Dow Inc.'s Current Report on Form 8-K filed with the SEC on April 2, 2019).
|
|
|
|
Amended and Restated Certificate of Incorporation of Dow Inc. (incorporated by reference to Exhibit 3.1 to Dow Inc.’s Current Report on Form 8-K filed with the SEC on April 2, 2019).
|
|
|
|
Amended and Restated Bylaws of Dow Inc. (incorporated by reference to Exhibit 3.2 to Dow Inc.’s Current Report on Form 8-K filed with the SEC on April 2, 2019).
|
|
|
|
Second Supplemental Indenture, dated May 20, 2019, between The Dow Chemical Company, Dow Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee, to the 2008 Indenture (incorporated by reference to Exhibit 4.1 to The Dow Chemical Company's Current Report on Form 8-K, filed with the SEC on May 20, 2019).
|
|
|
4.3
|
|
Dow Inc. agrees to provide the SEC, on request, copies of all other such indentures and instruments that define the rights of holders of long-term debt of Dow Inc. and its consolidated subsidiaries, including The Dow Chemical Company, pursuant to Item 601(b)(4)(iii)(A) of Regulation S-K.
|
|
|
Tax Matters Agreement, dated as of April 1, 2019, by and among DowDuPont Inc., Dow Inc., and Corteva, Inc. (incorporated by reference to Exhibit 10.1 to Dow Inc.’s Current Report on Form 8-K filed with the SEC on April 2, 2019).
|
|
|
|
Employee Matters Agreement, dated as of April 1, 2019, by and among DowDuPont Inc., Dow Inc., and Corteva, Inc. (incorporated by reference to Exhibit 10.2 to Dow Inc.’s Current Report on Form 8-K filed with the SEC on April 2, 2019).
|
|
|
|
MatCo/SpecCo Intellectual Property Cross License Agreement, dated as of April 1, 2019, by and between Dow Inc. et al and DowDuPont Inc. et al (incorporated by reference to Exhibit 10.3 to Dow Inc.’s Current Report on Form 8‑K filed with the SEC on April 2, 2019).
|
|
|
|
MatCo/AgCo Intellectual Property Cross License Agreement, dated as of April 1, 2019, by and between Dow Inc. et al and Corteva, Inc. et al (incorporated by reference to Exhibit 10.4 to Dow Inc.’s Current Report on Form 8-K filed with the SEC on April 2, 2019).
|
|
|
|
Dow Inc. 2019 Stock Incentive Plan effective as of April 1, 2019 (incorporated by reference to Exhibit 4.4 to Dow Inc.’s Registration Statement on Form S-3, filed with the SEC on April 1, 2019).
|
|
|
|
Form of Performance Stock Unit Award Agreement under the Dow Inc. 2019 Stock Incentive Plan effective as of April 1, 2019 (incorporated by reference to Exhibit 4.4.1 to Dow Inc.’s Registration Statement on Form S-3, filed with the SEC on April 1, 2019).
|
|
|
|
Form of Restricted Stock Award Agreement under the Dow Inc. 2019 Stock Incentive Plan effective as of April 1, 2019 (incorporated by reference to Exhibit 4.4.2 to Dow Inc.’s Registration Statement on Form S-3, filed with the SEC on April 1, 2019).
|
|
|
|
Form of Restricted Stock Unit Award Agreement under the Dow Inc. 2019 Stock Incentive Plan effective as of April 1, 2019 (incorporated by reference to Exhibit 4.4.3 to Dow Inc.’s Registration Statement on Form S-3, filed with the SEC on April 1, 2019).
|
|
|
|
Form of Stock Appreciation Right Award Agreement under the Dow Inc. 2019 Stock Incentive Plan effective as of April 1, 2019 (incorporated by reference to Exhibit 4.4.4 to Dow Inc.’s Registration Statement on Form S-3, filed with the SEC on April 1, 2019).
|
|
|
|
Form of Stock Option Award Agreement under the Dow Inc. 2019 Stock Incentive Plan effective as of April 1, 2019 (incorporated by reference to Exhibit 4.4.5 to Dow Inc.’s Registration Statement on Form S-3, filed with the SEC on April 1, 2019).
|
|
|
|
Form of Restricted Stock Unit Award Agreement (Director) under the Dow Inc. 2019 Stock Incentive Plan effective as of April 1, 2019 (incorporated by reference to Exhibit 4.4.6 to Dow Inc.’s Registration Statement on Form S-3, filed with the SEC on April 1, 2019).
|
|
|
|
The Dow Chemical Company Elective Deferral Plan (Pre-2005), restated and effective as of April 1, 2019 (incorporated by reference to Exhibit 10.8 to Dow Inc. and The Dow Chemical Company's Quarterly Report on Form 10-Q, filed with the SEC on May 3, 2019).
|
|
|
|
The Dow Chemical Company Elective Deferral Plan (Post 2004), restated and effective as of April 1, 2019 (incorporated by reference to Exhibit 4.1 to The Dow Chemical Company’s Registration Statement on Form S-8 POS, filed with the SEC on April 1, 2019).
|
|
|
|
Dow Inc. Voluntary Deferred Compensation Plan for Non-Employee Directors, restated and effective as of April 1, 2019 (incorporated by reference to Exhibit 10.10 to Dow Inc. and The Dow Chemical Company's Quarterly Report on Form 10‑Q, filed with the SEC on May 3, 2019).
|
|
|
23
*
|
|
Ankura Consulting Group, LLC's Consent.
|
|
31.1
*
|
|
Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
31.2
*
|
|
Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
32.1
*
|
|
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
32.2
*
|
|
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
101.INS
|
|
XBRL Instance Document.
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document.
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document.
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document.
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document.
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document.
|
Dow Inc. and Subsidiaries
The Dow Chemical Company and Subsidiaries
Signature
|
/s/ RONALD C. EDMONDS
|
Ronald C. Edmonds
|
Controller and Vice President
|
of Controllers and Tax
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
Customers
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|